<SEC-DOCUMENT>0001683168-20-001231.txt : 20200420
<SEC-HEADER>0001683168-20-001231.hdr.sgml : 20200420
<ACCEPTANCE-DATETIME>20200420161512
ACCESSION NUMBER:		0001683168-20-001231
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20200601
FILED AS OF DATE:		20200420
DATE AS OF CHANGE:		20200420
EFFECTIVENESS DATE:		20200420

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RadNet, Inc.
		CENTRAL INDEX KEY:			0000790526
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				133326724
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33307
		FILM NUMBER:		20802699

	BUSINESS ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		3104787808

	MAIL ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMEDEX HEALTH SYSTEMS INC
		DATE OF NAME CHANGE:	19930518

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CCC FRANCHISING CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>radnet_def14a.htm
<DESCRIPTION>DEFINITIVE PROXY STATEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE&nbsp;14A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Proxy Statement Pursuant to Section&nbsp;14(a)&nbsp;of
the Securities<BR>
Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Filed by the Registrant <FONT STYLE="font-family: Wingdings">&yacute;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Filed by a Party other than the Registrant
<FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Check the appropriate box:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Wingdings">&uml;</FONT>
Preliminary Proxy Statement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Wingdings">&uml;</FONT>
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Wingdings">&yacute;</FONT>
Definitive Proxy Statement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Wingdings">&uml;</FONT>
Definitive Additional Materials</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Wingdings">&uml;</FONT>
Soliciting Material Pursuant to &sect; 240.14a-12</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>RADNET,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of Registrant as Specified in its
Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>__________________________________________</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of Person(s) Filing Proxy
Statement, if other than the Registrant)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Payment of Filing Fee (Check the appropriate
box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Wingdings">&yacute;</FONT>
No fee required</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT>
Fee computed on table below per Exchange Act Rules 14a-6(i)(1)&nbsp;and 0-11.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%; text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="width: 73%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Title of each class of securities to which
        transaction applies:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P></TD>
    <TD STYLE="width: 20%; text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt">Not applicable</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Aggregate number of securities to which transaction
        applies:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P></TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt">Not applicable</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Per unit price or other underlying value of
        transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how
        it was determined):</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P></TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt">Not applicable</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">(4)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Proposed maximum aggregate value of transaction:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P></TD>
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">(5)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Total fee paid:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P></TD>
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT>
Fee paid previously with preliminary materials:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT>
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the
offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule
and the date of its filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%; text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="width: 93%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Amount Previously Paid:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Form, Schedule&nbsp;or Registration Statement
        No.:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Filing Party:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">Date Filed:</FONT></TD></TR>
<TR>
    <TD COLSPAN="2" STYLE="text-align: center; font-size: 10pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"><IMG SRC="image_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RADNET, INC.<BR>
1510 Cotner Ave.<BR>
Los Angeles, CA 90025<BR>
<BR>
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">April 20, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Stockholder:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On behalf of the Board of Directors and
management, we cordially invite you to attend the 2020 Annual Meeting of Stockholders of RadNet, Inc. (the &ldquo;Annual Meeting&rdquo;),
to be held at our principal executive office at 1510 Cotner Avenue, Los Angeles, CA 90025, on Monday, June 1, 2020, at 10:00 a.m.
(Pacific Time) or at any adjournment or postponement thereof. At this meeting, stockholders will vote on matters set forth in the
accompanying Notice of Annual Meeting of Stockholders and Proxy Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also enclose a copy of our annual report
on Form 10-K for our fiscal year ended December 31, 2019 (the &ldquo;2019 Annual Report&rdquo;). We encourage you to read our 2019
Annual Report, which includes information on our business, as well as our audited financial statements for the fiscal year ended
December 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This year we are again taking advantage
of the Securities and Exchange Commission rule that permits us to furnish proxy materials to our stockholders via the Internet.
On or about April 20, 2020, we are mailing a short Notice of Internet Availability of Proxy Materials (the &ldquo;Notice of Availability&rdquo;)
to most of our stockholders instead of a paper copy of our full proxy materials. The Notice of Availability contains instructions
on how to access our proxy materials, including the Notice of Annual Meeting of Stockholders, Proxy Statement, 2019 Annual Report
and a Proxy Card or voting instruction form and on how to cast your vote online or by phone. The Notice of Availability also contains
instructions on how to request a paper copy of our proxy materials. All stockholders who do not receive the Notice of Availability
will receive a paper copy of the proxy materials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Your vote is very important. Regardless
of the number of shares you own, please vote. Whether or not you plan to attend the Annual Meeting, we hope you will vote as soon
as possible.</B> You may vote by submitting your proxy via the Internet, by phone, or if you have elected to receive printed proxy
materials, by completing, signing, dating and returning the Proxy Card enclosed with your printed proxy materials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you for your continued support and
ownership of RadNet, Inc. We look forward to seeing you at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 50%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sincerely,</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD><IMG SRC="image_004.jpg" ALT="">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD><P STYLE="margin-top: 0; margin-bottom: 0">John V. Crues, III, M.D.</P>
        <P STYLE="margin-top: 0; margin-bottom: 0"><I>Corporate Secretary</I></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Important
Notice Regarding Availability of Proxy Materials for the 2020 Annual Meeting of Stockholders: </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<BR>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Proxy Statement for the 2020 Annual
Meeting of Stockholders, the Proxy Card and the 2019 Annual Report are available at <I>www.proxyvote.com</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RADNET, INC.<BR>
1510 Cotner Ave.<BR>
Los Angeles, CA 90025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS<BR>
JUNE 1, 2020</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">RadNet, Inc. will hold
its 2020 Annual Meeting of Stockholders (the &ldquo;Annual Meeting&rdquo;) on Monday, June 1, 2020, at 10:00 a.m. (Pacific Time)
or any adjournment or postponement thereof, at our principal executive office at 1510 Cotner Avenue, Los Angeles, CA 90025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following items
are on the agenda and are more fully described in the accompany Proxy Statement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 48px; text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">1.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">The election of seven nominees named in the attached Proxy Statement as directors to hold office until the 2021 Annual Meeting of Stockholders;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">2.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">The ratification of the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">3.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">A non-binding advisory vote to approve executive compensation;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-size: 10pt">4.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">Other business that may properly come before the Annual Meeting.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board of Directors
has fixed April 6, 2020 as the record date for determining stockholders entitled to notice of, and to vote at, the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are mailing to
our stockholders on or about April 20, 2020, a Notice of Internet Availability of Proxy Materials containing instructions on how
to access our Proxy Statement and our annual report on Form 10-K for our fiscal year ended December 31, 2019, via the Internet
and how to vote online or by phone. The Notice of Internet Availability of Proxy Materials also contains instructions on how you
can receive a paper copy of the proxy materials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 50%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">By Order of the Board of Directors,</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD><IMG SRC="image_004.jpg" ALT="">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD><P STYLE="margin-top: 0; margin-bottom: 0">John V. Crues, III, M.D.</P>
        <P STYLE="margin-top: 0; margin-bottom: 0"><I>Corporate Secretary</I></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B>April 20, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Los Angeles, California</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Whether or not you
expect to attend the Annual Meeting, please vote as soon as possible to ensure your representation at the Annual Meeting. You may
vote via the Internet, by phone, or if you have elected to receive printed proxy materials, by completing, signing, dating and
returning the Proxy Card enclosed with your printed proxy materials. Even if you have given your proxy, you may still vote in person
if you attend the meeting. Please note, however, that if a broker, bank or other nominee holds your shares of record and you wish
to vote at the Annual Meeting, then you must obtain from the record holder a proxy issued in your name.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>We are actively
monitoring the public health and travel concerns relating to COVID-19 and the related recommendations and protocols issued by
federal, state and local governments. In the event that it is not possible or advisable to hold our Annual Meeting at the time,
date and place as originally planned, we will announce alternative arrangements for the meeting as promptly as practicable, which
may include holding the meeting solely by means of remote communication. Any such change, including details on how to participate
in a remote meeting, would be announced in advance via press release, a copy of which would be filed with the SEC as additional
proxy solicitation materials and available via the Internet. As always, we encourage you to vote your shares prior to the Annual
Meeting.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_002.jpg" ALT=""><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RADNET, INC.<BR>
1510 Cotner Ave.<BR>
Los Angeles, CA 90025<BR>
<BR>
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROXY STATEMENT<BR>
FOR ANNUAL MEETING OF STOCKHOLDERS<BR>
TO BE HELD JUNE 1, 2020<BR>
<BR>
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board of Directors
of RadNet, Inc., a Delaware corporation (&ldquo;RadNet&rdquo;), is providing these proxy materials to you in connection with the
solicitation of the accompanying proxy for use at our 2020 Annual Meeting of Stockholders (the &ldquo;Annual Meeting&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Annual Meeting
will be held at our principal executive office at 1510 Cotner Avenue, Los Angeles, CA 90025, on Monday, June 1, 2020, at 10:00
a.m. (Pacific Time) or at any adjournment or postponement thereof, for the purposes stated herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On or about April
20, 2020 we are mailing a Notice of Internet Availability of Proxy Materials (the &ldquo;Notice of Availability&rdquo;)
containing instructions on how to access our Proxy Statement and our annual report on Form 10-K for our fiscal year ended
December 31, 2019 (the &ldquo;2019 Annual Report&rdquo;), via the Internet and how to vote online or by phone. The Notice of
Availability also contains instructions on how you can receive a paper copy of the proxy materials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Proxy Statement
summarizes certain information to assist you in voting in an informed manner.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All stockholders are
cordially invited to attend the Annual Meeting in person. Whether you expect to attend the meeting or not, please vote as soon
as possible.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>We are actively
monitoring the public health and travel concerns relating to COVID-19 and the related recommendations and protocols issued by federal,
state and local governments. In the event that it is not possible or advisable to hold our Annual Meeting at the time, date and
place as originally planned, we will announce alternative arrangements for the meeting as promptly as practicable, which may include
holding the meeting solely by means of remote communication. Any such change, including details on how to participate in a remote
meeting, would be announced in advance via press release, a copy of which would be filed with the SEC as additional proxy solicitation
materials and available via the Internet. As always, we encourage you to vote your shares prior to the Annual Meeting.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">TABLE OF CONTENTS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Page</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 90%; text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 0.5in"><A HREF="#a01">THE PROXY PROCESS AND THE ANNUAL MEETING</A></TD>
    <TD STYLE="width: 10%; text-align: right; padding-top: 3pt; padding-bottom: 0pt">1</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 0.5in"><A HREF="#a02">CORPORATE GOVERNANCE</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">6</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a03">Role of the Board of Directors</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">6</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a04">Board Leadership Structure</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">6</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a05">Director Independence</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">6</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a06">Committees of the Board of Directors</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">6</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a07">Board Role in Risk Oversight</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">8</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a08">Code of Financial Ethics</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">9</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a09">Review and Approval of Related Party Transactions</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">9</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a10">Board Attendance at Annual Meetings of Stockholders</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">10</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a11">Compensation Committee Interlocks and Insider Participation</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">10</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a12">Communication with our Board of Directors</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">10</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 0.5in"><A HREF="#a13">DIRECTORS</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">11</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a14">Nomination Process</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">11</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a15">Nominees for Election</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">11</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 0.5in"><A HREF="#a16">COMPENSATION OF DIRECTORS</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">14</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a17">Overview of Director Compensation</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">14</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a18">Cash Compensation Paid to Non-Employee Board Members</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">14</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a40">Equity Compensation</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">14</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a19">Nonqualified Deferred Compensation Arrangements</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">15</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a20">Non-Employee Director Compensation</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">15</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 0.5in"><A HREF="#a21">EXECUTIVE OFFICERS</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">16</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 0.5in"><A HREF="#a22">COMPENSATION COMMITTEE REPORT</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">18</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 0.5in"><A HREF="#a23">COMPENSATION DISCUSSION AND ANALYSIS</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">19</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a24">Compensation Philosophy</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">19</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a25">Board and Committee Process</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">20</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a26">Elements of Executive Compensation</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">22</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a27">Pay Ratio Disclosure</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">25</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a28">2019 Compensation Determinations</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">26</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a29">2019 Stockholder Advisory Vote on Executive Compensation</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">27</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a30">2020 Compensation Determinations</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">27</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a31">Taxes, Risks and other Considerations</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">28</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 0.5in; width: 90%"><A HREF="#a32">EXECUTIVE COMPENSATION TABLES</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt; width: 10%">30</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a33">Summary Compensation Table</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">30</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a34">Grants of Plan-Based Awards</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">31</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a35">Outstanding Equity Awards at Fiscal Year End</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">32</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a36">Option Exercises and Stock Vested During 2019</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">33</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a37">Pension Benefits, Nonqualified Defined Contribution and Other Deferred Compensation Plans</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">34</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a38">Employment Agreements</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">35</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 1in"><A HREF="#a39">Potential Payments Upon Termination or Change in Control</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">36</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 0.5in"><A HREF="#a40">EQUITY COMPENSATION PLAN INFORMATION</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">38</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 0.5in"><A HREF="#a41">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">39</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 0.5in"><A HREF="#a42">DELINQUENT SECTION 16(A) REPORTS</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">42</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 0.5in"><A HREF="#a43">REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">43</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 0.5in"><A HREF="#a44">PROPOSALS</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">44</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 0.5in"><A HREF="#a45">OTHER MATTERS</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">47</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 3pt; padding-bottom: 0pt; padding-left: 0.5in"><A HREF="#a46">ADDITIONAL INFORMATION</A></TD>
    <TD STYLE="text-align: right; padding-top: 3pt; padding-bottom: 0pt">47</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B></B></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a01"></A>THE PROXY PROCESS AND THE ANNUAL MEETING</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following discussion
is intended to provide general information about the proxy process and the Annual Meeting under the rules and regulations of the
Securities and Exchange Commission (the &ldquo;SEC&rdquo;). If you have additional questions about this Proxy Statement or the
Annual Meeting, please contact our Corporate Secretary at: RadNet, Inc., 1510 Cotner Avenue, Los Angeles, CA 90025, Attention:
Corporate Secretary, Telephone: (310) 445-2800.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>2020 Annual Meeting of Stockholders</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%">&nbsp;</TD>
    <TD STYLE="width: 55%; text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">RADNET, INC.</FONT></TD>
    <TD STYLE="width: 30%; text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">June 1, 2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">1510 Cotner Ave.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">10:00 a.m. Pacific Time</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">Los Angeles, CA 90025</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Record Date for
the Annual Meeting is April 6, 2020 (the &ldquo;Record Date&rdquo;). Only stockholders of record as of the close of business on
this date are entitled to vote at the Annual Meeting. You are invited to vote on the proposals described in this Proxy Statement
because you were a RadNet stockholder on the Record Date. RadNet is soliciting proxies for use at the Annual Meeting, including
any postponements or adjournments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>Attending the Annual Meeting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you are a stockholder
of record, you have the right to vote in person at the Annual Meeting. You will need to bring either the Notice of Availability
or any Proxy Card that is sent to you to the meeting. Otherwise, you will be admitted only if we can verify your ownership of common
stock on the Record Date. If you own shares held in street name, bring with you to the meeting either the Notice of Availability
or any voting instruction form that is sent to you, or your most recent brokerage statement or a letter from your bank, broker
or other record holder indicating that you beneficially owned shares of our common stock on the Record Date. We can use that to
verify your beneficial ownership of common stock and admit you to the meeting. Additionally, all persons will need to bring
a valid government-issued photo ID to gain admission to the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Even if you plan
to attend the Annual Meeting, we recommend that you submit your proxy or voting instructions in advance of the meeting as described
below so that your vote will be counted if you later decide not to attend the Annual Meeting.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Purpose</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">At the Annual Meeting,
our stockholders will vote on the following items:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">The
election of seven nominees named in this Proxy Statement as directors to hold office until the 2021 Annual Meeting of Stockholders;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">The
ratification of the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year
ending December 31, 2020;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD>A
non-binding advisory vote to approve executive compensation; and</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD>Other
business that may properly come before the Annual Meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Proxy Materials </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These proxy materials
were first sent or made available to stockholders on April 20, 2020, and include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD>Notice
of Annual Meeting of Stockholders</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD>This
Proxy Statement for the Annual Meeting</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD>RadNet&rsquo;s
Annual Report on Form 10-K for the year ended December 31, 2019</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you requested printed
versions by mail, these printed proxy materials also include the Proxy Card or voting instruction form for the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Internet Availability </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">RadNet uses the Internet
as the primary means of furnishing proxy materials to our stockholders. We are sending a Notice of Internet Availability of Proxy
Materials (the &ldquo;Notice of Availability&rdquo;) to our stockholders with instructions on how to access the proxy materials
online or request a printed copy of the materials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Stockholders may follow
the instructions in the Notice of Availability to elect to receive future proxy materials in print by mail or electronically by
email. We encourage stockholders to take advantage of the availability of the proxy materials online to help reduce the environmental
impact of our annual meetings and reduce RadNet&rsquo;s printing and mailing costs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Quorum for the Annual Meeting </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: Black">Holders
of a majority of the shares entitled to vote at the Annual Meeting must be present at the Annual Meeting in person or by proxy
for the transaction of business. This is called a quorum. On the Record Date 50,694,735 shares of our common stock were issued
and outstanding. Consequently, we will need to have 25,347,368 shares present in person or represented by proxy at the Annual
Meeting in order to establish a quorum. Your shares will be counted for purposes of determining if there is a quorum if:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD><FONT STYLE="color: Black">You
                                         are entitled to vote and you are present in person at the Annual Meeting; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: Black">You
                                         have properly voted by proxy online, by phone, or by submitting a Proxy Card or voting
                                         instruction form by mail.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #3F3F3F; text-indent: 0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #3F3F3F; text-indent: 0.5in"><FONT STYLE="color: Black">Broker
non-votes and abstentions are counted for purposes of determining whether a quorum is present. If a quorum is not present, we
may propose to adjourn the Annual Meeting to solicit additional proxies and reconvene the Annual Meeting at a later date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #3F3F3F; text-indent: 0.5in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black"><B>Inspector of
Election</B></FONT><B> </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An officer of RadNet
will count the votes and act as the inspector of elections. The inspector of elections will separately tabulate affirmative and
negative votes, abstentions and broker non-votes. RadNet has also engaged Broadridge Financial Solutions, Inc. as its proxy distribution
agent and tabulation service provider and they will also be calculating the votes received prior to the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>Proxy Solicitation Costs </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">RadNet is paying the
costs of the solicitation of proxies. We will also make available solicitation materials to banks, brokerage houses, fiduciaries
and custodians holding in their names shares of our common stock that are beneficially owned by others for forwarding to the beneficial
owners. We may reimburse persons representing beneficial owners of common stock for their costs of forwarding solicitation materials
to the beneficial owners. Solicitations will be made primarily through the mail, but may be supplemented by telephone, facsimile,
Internet or personal solicitation by our directors, executive officers and employees. No additional compensation will be paid
to these individuals for these services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Voting </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each share of RadNet&rsquo;s
common stock has one vote on each matter. Only &ldquo;stockholders of record&rdquo; as of the close of business on the Record
Date are entitled to vote at the Annual Meeting. In addition to stockholders of record of RadNet&rsquo;s common stock, &ldquo;beneficial
owners of shares held in street name&rdquo; as of the Record Date can vote using the methods described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you are a stockholder
who holds stock in &ldquo;street name&rdquo; you will likely receive instructions for voting your shares from your broker, bank,
or other nominee rather than through our voting system. A number of brokers and banks participate in a program that allows stockholders
to grant their proxy to vote shares by means of the telephone or the Internet. If your shares are held in an account with a broker
or bank participating in such a program, then you may vote your shares via the Internet or telephonically by following the instructions
on the form received from your broker or bank.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Stockholders who submit a proxy by Internet or telephone need not return a Proxy Card
or the form forwarded by your broker, bank, trust or other holder of record by mail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With respect to the
election of directors, stockholders may vote for all nominees, withhold authority for all nominees or vote for all except for
those individual nominees for director for which the stockholder indicates it is withholding authority. With respect to each other
proposal, stockholders may vote &ldquo;FOR&rdquo; the proposal, &ldquo;AGAINST&rdquo; the proposal, or abstain from voting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Voting Procedures</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are four ways
to vote:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><B>Online</B>.
You may vote by proxy by visiting proxyvote.com and entering the control number found in the Notice of Availability. The availability
of online voting may depend on the voting procedures of the organization that holds your shares.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><B>In
Person</B>. You may vote in person at the Annual Meeting by requesting a ballot. Only eligible stockholders will be admitted to
the Annual Meeting. If you are a beneficial owner of shares held in street name and wish to vote in person at the Annual Meeting,
you must also obtain a &ldquo;legal proxy&rdquo; from the organization that holds your shares. A legal proxy is a written document
that authorizes you to vote your shares held in street name at the Annual Meeting. Please contact the organization that holds
your shares for instructions regarding obtaining a legal proxy. You must bring a copy of the legal proxy to the Annual Meeting.
In order for your vote to be counted, you must hand both the copy of the legal proxy and your completed ballot to an usher to
be provided to the inspector of election.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><B>Phone</B>.
If you request printed copies of the proxy materials by mail, you will receive a Proxy Card or voting instruction form and you
may vote by proxy by calling the toll-free number found on the card or form. The availability of phone voting may depend on the
voting procedures of the organization that holds your shares.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><B>Mail</B>.
If you request printed copies of the proxy materials by mail, you will receive a Proxy Card or voting instruction form and you
may vote by proxy by filling out the card or form and returning it in the envelope provided.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All shares represented
by valid proxies received prior to the taking of the vote at the Annual Meeting will be voted and, where a stockholder specifies
by means of the proxy a choice with respect to any matter to be acted upon, the shares will be voted in accordance with the stockholder&rsquo;s
instructions. Even if you plan on attending the Annual Meeting in person, we encourage you to vote your shares in advance online,
by phone, or by mail to ensure that your vote will be represented at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Changing your Vote </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You may revoke your proxy and change your
vote at any time before the taking of the vote at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><B>Online</B>.
You may change your vote using the online voting method described above, in which case only your latest Internet proxy submitted
prior to the Annual Meeting will be counted.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><B>In
Person</B>. You may revoke your proxy and change your vote by attending the Annual Meeting and voting in person. However, your
attendance at the Annual Meeting will not automatically revoke your proxy unless you properly vote at the Annual Meeting or specifically
request that your prior proxy be revoked by delivering a written notice of revocation prior to the Annual Meeting to RadNet&rsquo;s
Corporate Secretary.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><B>Phone</B>.
You may change your vote using the phone voting method described above, in which case only your latest telephone proxy submitted
prior to the Annual Meeting will be counted.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><B>Mail</B>.
You may revoke your proxy and change your vote by signing and returning a new Proxy Card or voting instruction form dated as of
a later date, in which case only your latest Proxy Card or voting instruction form received prior to the Annual Meeting will be
counted.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Routine and Non-Routine Proposals </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following proposal
is considered a routine matter:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">The
ratification of the appointment of Ernst &amp; Young LLP as RadNet&rsquo;s independent registered public accounting firm for 2020
(Proposal No. 2).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A broker or other nominee
may generally vote in their discretion on routine matters, and therefore no broker non-votes are expected in connection with Proposal
No. 2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following proposals
are considered non-routine matters:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD>Election
of directors (Proposal No. 1); and</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD>Advisory
vote to approve executive compensation (Proposal No. 3)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the organization
that holds your shares does not receive instructions from you on how to vote your shares on a non-routine matter, that organization
will inform the inspector of election that it does not have the authority to vote on the matter with respect to your shares. This
is generally referred to as a &ldquo;broker non-vote.&rdquo; Therefore, broker non-votes may exist in connection with Proposal
No. 1 and Proposal No. 3. You must instruct your bank, broker or nominee on how to vote your shares for Proposal No. 1 and Proposal
No. 3 in order for your vote to count for those proposals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Vote Required to Approve a Proposal
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With respect to the
election of directors (Proposal No. 1), RadNet&rsquo;s bylaws provide that, in an uncontested election of directors, the affirmative
vote of a majority of the shares present or represented by proxy and voting at the Annual Meeting is required to elect a director.
An &ldquo;uncontested election of directors&rdquo; means an election of directors in which the number of candidates for election
does not exceed the number of directors to be elected by the stockholders at that election.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Approval of Proposals
No. 2 and No. 3 requires, in each case, the affirmative vote of a majority of the shares present or represented by proxy and voting
at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Broker Non-Votes and Abstentions </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Shares that constitute
broker non-votes will be counted as present for purposes of establishing a quorum, but will not be counted as having voting power
to vote on the proposal in question. Under the applicable rules of the exchanges and other self-regulatory organizations, brokers
will generally have discretionary authority to vote on routine matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Uninstructed Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you are a record
holder and submit a valid proxy or voting instruction form but do not indicate your specific voting instructions on one or more
of the proposals listed in the Notice of Availability, your shares will be voted as recommended by our Board of Directors on those
proposals and as the proxyholders may determine in their discretion with respect to any other matters properly presented for a
vote at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Confidentiality of Votes </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Proxy instructions,
ballots, and voting tabulations that identify individual stockholders are handled in a manner that protects your voting privacy.
Your vote will not be disclosed either within RadNet or to third parties, except: (1) as necessary to meet applicable legal requirements
and (2) to allow for the tabulation of votes and certification of the vote. Occasionally, stockholders include additional comments
on their Proxy Card or with their voting instruction, which are then forwarded to our management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Tabulation and Reporting of Voting Results
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Preliminary voting
results will be announced at the Annual Meeting. Final voting results will be tallied by the inspector of election after the taking
of the vote at the Annual Meeting. RadNet will publish the final voting results in a Current Report on Form 8-K filed with the
SEC within four business days following the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Director Nominations and Stockholder
Proposals for Inclusion in RadNet, Inc.&rsquo;s 2021 Proxy Materials.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our bylaws provide
that, for stockholder nominations to the Board of Directors or other proposals to be considered at an annual meeting, the stockholder
must have given timely advance notice of the proposal or nomination in writing to our Corporate Secretary. To be timely for the
2021 Annual Meeting of Stockholders, a stockholder&rsquo;s notice must be delivered to or mailed and received by our Corporate
Secretary at our principal executive offices between February 4, 2021 and March 5, 2021. A stockholder&rsquo;s notice to the Corporate
Secretary must set forth, as to each matter the stockholder proposes to bring before the annual meeting, the information required
by our bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Stockholder proposals
submitted pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;) must be
received by us not later than December 21, 2020, in order to be considered for inclusion in our proxy materials for the 2021 Annual
Meeting of Stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a02"></A>CORPORATE GOVERNANCE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a03"></A>Role of the Board of Directors</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business is managed
under the direction of our Board of Directors. Our Board of Directors provides oversight, strategic direction and counsel to our
management. In addition, our Board of Directors elects our officers, delegates responsibilities for the conduct of our operations
to those officers, and evaluates their performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board of Directors
held four meetings during 2019 and took action by written consent on one occasion. Each of our directors serving in 2019 attended
at least 75% of the total number of meetings of the Board of Directors and applicable committees that each director was eligible
to attend.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a04"></A>Board Leadership Structure</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Chairman of the
Board of Directors, Dr. Berger, also serves as our Chief Executive Officer. Our Board of Directors has determined that this leadership
structure is appropriate and effective for RadNet at this time. This structure effectively utilizes Dr. Berger&rsquo;s knowledge
of RadNet and the industry in which we operate, while fostering greater communication and producing a greater degree of transparency
between management and our directors. Dr. Berger co-founded RadNet in 1980 and has served as Chairman of the Board and Chief Executive
Officer for nearly 40 years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">David L. Swartz
currently serves as Lead Independent Director of the Board of Directors. In this capacity, Mr. Swartz serves as Chairman of
meetings of the Board of Directors in the absence of the Chairman of the Board, calls, sets the agenda, and chairs the
executive sessions of the independent directors, works collaboratively with the Chairman of the Compensation and Management
Development Committee to oversee the evaluation of our Chief Executive Officer and serves as the liaison between the
independent directors and the Chairman of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a05"></A>Director Independence</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Four of the seven members
of our Board of Directors are independent directors and only those individuals may serve on the committees of our Board of Directors.
Our Chairman and Chief Executive Officer does not serve on any committee. Our Board of Directors holds regular executive sessions
outside the presence of the Chief Executive Officer and other management, which our Board of Directors believes promotes appropriate
independent leadership.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board of
Directors annually determines the independence of our directors in accordance with the independence requirements under the
NASDAQ Stock Market LLC (&ldquo;NASDAQ&rdquo;) and the SEC rules which require at least a majority of the directors to be
independent. As a result of this review, our Board of Directors has determined that Marvin S. Cadwell, Lawrence L. Levitt,
Michael L. Sherman, M.D. and David L. Swartz each qualifies as an independent director in accordance with the NASDAQ and the
SEC rules. Each of Howard G. Berger, M.D., John V. Crues, III, M.D., and Ruth Wilson is an executive officer of RadNet and
therefore does not qualify as an independent director under the NASDAQ and the SEC rules. If elected, Laura P. Jacobs would
qualify as an independent director under the NASDAQ and the SEC rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a06"></A>Committees of the Board of Directors</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have three standing
committees: the Audit Committee, the Compensation and Management Development Committee and the Nominating and Governance Committee.
The committees are comprised entirely of independent directors. Each committee operates under a written charter adopted by the
Board of Directors which is available at <I>www.radnet.com</I> under Investor Relations &ndash; Corporate Governance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The composition of
those committees is as set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom; width: 34%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Director</B></P></TD>
    <TD STYLE="padding-bottom: 1pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; width: 21%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Audit Committee</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; width: 21%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Compensation and Management <BR>
Development Committee</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; width: 21%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Nominating and Governance Committee</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #EEEEEE">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Lawrence L. Levitt</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">X</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">C</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">X</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Marvin S. Cadwell</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">X</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">X</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">X</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #EEEEEE">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Michael Sherman, M.D.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">X</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">C</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">David L. Swartz</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">C</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">X</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">X</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>________________________</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;C&rdquo; denotes chair of committee</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><I><U>Audit Committee</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee&rsquo;s
responsibilities include, among other things:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">overseeing our accounting and financial reporting processes and the audits of our financial statements;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">overseeing, along with management, the reliability and integrity of our accounting policies and financial reporting and disclosure practices;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">serving as an independent and objective party to monitor our financial reporting processes and internal controls systems;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">retaining our independent registered public accounting firm, reviewing and evaluating their independence, qualifications and performance, approving the terms of the annual engagement letter and approving all audit and non-audit services to be performed by our independent registered public accounting firm; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">providing independent, direct, and open communications among our independent registered public accounting firm, financial and senior management and the full Board of Directors.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board of Directors
has determined that each of Mr. Swartz and Mr. Levitt qualifies as an &ldquo;audit committee financial expert&rdquo; as defined
under the applicable SEC rules and that each member of the Audit Committee meets the additional criteria for independence of Audit
Committee members under Rule 10A-3(b)(1) of the Exchange Act. The Audit Committee held four meetings in 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><I><U>Compensation and Management
Development Committee</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation and
Management Development Committee&rsquo;s responsibilities include, among other things:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">reviewing and determining the base salary of executive officers and certain other senior management and setting the maximum bonus amount that each executive officer (other than the Chief Executive Officer) and certain other senior management is entitled to receive, which may be in the form of cash or equity incentive awards, as ultimately determined by our Chief Executive Officer;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">reviewing and administering our
equity incentive plans, including any amendments thereto;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">reviewing and recommending amounts and types of compensation for our directors;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">overseeing our compensation philosophy and strategy;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: left"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">monitoring compliance with rules and regulations relating to compensation arrangements for our directors and executive officers; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: left"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">reviewing and approving our corporate goals and objectives
    relevant to Chief Executive Officer compensation and evaluating the Chief Executive Officer&rsquo;s performance in light of
    those goals and determining the Chief Executive Officer&rsquo;s compensation levels and bonus based on such
    evaluation.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation and
Management Development Committee held one meeting and took action by written consent on two occasions in 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I><U>Nominating
and Governance Committee</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Nominating and
Governance Committee&rsquo;s responsibilities include, among other things:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">developing and recommending the criteria to be used in screening and evaluating potential candidates or nominees for election or appointment as director;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">establishing and overseeing a policy for considering stockholder nominees for directors, and developing the procedures that must be followed by stockholders in submitting recommendations;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">monitoring and reviewing any issues regarding the independence of directors or involving potential conflicts of interest and evaluating any change of status or circumstances with respect to a director;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">evaluating all nominees for election of directors;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">developing and recommending to the Board of Directors, as necessary, corporate governance policies to be adopted and maintained;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">identifying committee member qualifications and recommending appropriate committee member appointments to the Board of Directors; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">establishing and reviewing annually with the Board of Directors the procedures for stockholders to send communications to the Board of Directors.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Nominating and
Governance Committee held two meetings in 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a07"></A>Board Role in Risk
Oversight</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board of Directors
performs an oversight role in managing RadNet&rsquo;s risk. In reviewing our strategy, business plan, budgets and historical and
anticipated future major transactions, the Board of Directors considers, among other factors, the risks RadNet faces, and how such
risks can be appropriately managed. While our Board of Directors oversees risk management strategy, our management is responsible
for implementing and supervising day to day risk management processes. Our senior management regularly reports to the Board of
Directors on areas of material risk, including operational, financial, legal and strategic risks, which enables the Board of Directors
to understand management&rsquo;s views and strategies regarding risk identification, risk management and risk mitigation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to the
oversight role assumed by the full Board of Directors, various committees of the Board of Directors also have responsibility for
risk management. The Director of Internal Audit reports directly to our Audit Committee on areas of material financial risk, including
internal controls, and the Audit Committee reports to the full Board of Directors on risks identified by the Director of Internal
Audit that the Audit Committee believes to be material. In addition, the Compensation and Management Development Committee oversees
the risks associated with our compensation policies and practices to ensure that the compensation programs and incentives do not
encourage short term risk taking at the expense of long term results or create risks that may have a material adverse effect on
RadNet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a08"></A>Code of Financial Ethics</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have adopted a written
Code of Financial Ethics that is applicable to our directors, officers and employees and is designed to deter wrongdoing and to
promote:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: left"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">honest and ethical conduct;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: left"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">full, fair, accurate, timely and understandable disclosure in reports and documents that we file with the SEC and in other public communications;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: left"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">compliance with applicable laws, rules and regulations, including insider trading compliance; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: left"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">accountability for adherence to the code and prompt internal reporting of violations of the code, including illegal or unethical behavior regarding accounting or auditing practices.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You may obtain a copy
of our Code of Financial Ethics on our website at <I>www.radnet.com</I> under Investor Relations &ndash; Corporate Governance.
The Board of Directors has designated the Audit Committee to be responsible for reviewing the Code of Financial Ethics and making
any appropriate updates or amendments. We intend to disclose any changes in this code or waivers from this code that apply to our
principal executive officer, principal financial officer, or principal accounting officer by posting such information to our website
or by filing with the SEC a Current Report on Form 8-K, in each case if such disclosure is required by SEC or Nasdaq rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a09"></A>Review and Approval of Related Party
Transactions</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a matter of policy,
the Board of Directors reviews and determines whether or not to approve any transaction between RadNet and its directors, director
nominees, executive officers and greater than 5% beneficial owners and each of their respective immediate family members where
the amount involved in the transaction exceeds or is expected to exceed $120,000 in a single year and the related party has or
will have a direct or indirect interest in the transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Related Party Transactions</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Howard G. Berger, M.D.,
is our President and Chief Executive Officer, a member of our Board of Directors, and also owns, indirectly, 99% of the equity
interests in Beverly Radiology Medical Group, Inc. (&ldquo;BRMG&rdquo;). BRMG is responsible for the professional medical services
at nearly all of our facilities located in California under a management agreement with us, and employs physicians or contracts
with various other independent physicians and physician groups to provide the professional medical services at most of our California
facilities. We generally obtain professional medical services from BRMG in California, rather than provide such services directly
or through subsidiaries, in order to comply with California&rsquo;s prohibition against the corporate practice of medicine. We
have a management agreement with BRMG, that expires on January 1, 2024 but includes an automatic renewal for consecutive 10-year
periods. Under our management agreement, BRMG pays us, as compensation for the use of our facilities and equipment and for our
services, a percentage of the gross amounts collected for the professional services it renders. The percentage, which was 79% at
December 31, 2019, is adjusted, if necessary, to ensure that the parties receive fair value for the services they render. In operation
and historically, the annual revenue of BRMG from all sources closely approximates its expenses, including Dr. Berger&rsquo;s compensation,
fees payable to us and amounts payable to third parties. <FONT STYLE="font-family: Times New Roman, Times, Serif">Dr. Berger also
owns a controlling interest in two medical groups that provide professional medical services to one of our imaging facilities located
in New York. In 2019, Dr. Berger received $500,000 of his salary and his entire bonus payment from an affiliate of BRMG, a consolidated
entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">John V. Crues, III,
M.D. is our Medical Director, Corporate Secretary, a member of our Board of Directors and a 1% owner of BRMG. Dr. Crues receives
all of his salary from BRMG. Dr. Crues also owns a controlling interest in multiple medical groups that provide professional medical
services to some of our imaging facilities located in New York, Delaware and Maryland.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a10"></A>Board Attendance at Annual Meetings
of Stockholders</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We, as a matter of
policy, encourage our directors to attend meetings of stockholders but we do not require attendance. Three of the seven directors
attended the 2019 Annual Meeting of Stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a11"></A>Compensation Committee Interlocks
and Insider Participation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Messrs. Levitt, Cadwell,
Sherman and Swartz were members of the Compensation and Management Development Committee in 2019. No member of the Compensation
and Management Development Committee has had a relationship with RadNet or any of its subsidiaries other than as a director and
stockholder and no member has been an officer or employee of RadNet or any of its subsidiaries, a participant in a &ldquo;related
person&rdquo; transaction or an executive officer of another entity where one of our executive officers serves on the Board of
Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a12"></A>Communication with our Board of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Stockholders may communicate
with our Board of Directors through the Corporate Secretary by writing to the following address: Board of Directors, c/o Corporate
Secretary, RadNet, Inc., 1510 Cotner Avenue, Los Angeles, CA 90025. The envelope containing such communication should contain a
clear notation that the letter is &ldquo;Stockholder-Board Communication&rdquo; or &ldquo;Stockholder-Director Communication&rdquo;
or a similar statement to indicate it is intended for the Board of Directors. All such communications must clearly indicate the
author as a stockholder and state whether the intended recipients are all members of the Board of Directors or just certain specified
directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a13"></A>DIRECTORS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a14"></A>Nomination Process</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Nominating and
Governance Committee recommends nominees to the Board of Directors for election after carefully considering all candidates, taking
into account all factors the Committee considers appropriate, which may include career specialization, relevant technical skills
or financial acumen, diversity of viewpoint, industry knowledge and the qualifications set forth in the Nominating and Governance
Committee Charter. Our Nominating and Governance Committee does not have a formal policy with regard to the consideration of diversity
in the identification of director nominees. However, as part of its evaluation of Board composition, the Nominating and Governance
Committee considers the diversity of candidates to ensure that our Board of Directors is comprised of individuals with a broad
range of experiences and backgrounds (including, among other things, career specialization, relevant technical skills or financial
acumen, diversity of viewpoint and industry knowledge) who can contribute to the Board&rsquo;s overall effectiveness in carrying
out its responsibilities and can represent diverse viewpoints on our Board of Directors. The Nominating and Governance Committee
assesses the effectiveness of these efforts when evaluating the composition of the Board of Directors as part of the annual nomination
process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Nominating
and Governance Committee considers stockholder nominees made in accordance with our bylaws, and evaluates candidates recommended
by stockholders in the same manner as all other candidates brought to the attention of the Nominating and Governance Committee.
Stockholder recommendations may be submitted to the Nominating and Governance Committee in care of the Corporate Secretary at the
address set forth under &ldquo;Communication with Our Board of Directors.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a15"></A>Nominees for Election</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The names of the director
nominees, their ages as of March 31, 2020, and other information about them are set forth below. Six of the seven nominees currently
serve on the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 26%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Name of Director Nominee</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 9%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 51%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Position</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 8%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Our<BR>
Director Since</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #EEEEEE">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Howard G. Berger, M.D.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">74</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Chief Executive Officer and Chairman of the Board</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">1992</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Marvin S. Cadwell</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">76</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">2007</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #EEEEEE">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">John V. Crues, III, M.D.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">70</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Director, Vice President, Medical Director</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">2000</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Lawrence L. Levitt</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">77</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">2005</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #EEEEEE">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">David L. Swartz</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">76</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">2004</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Ruth V. Wilson</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">57</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Director, Senior Vice President of Human Resources</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">2019</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #EEEEEE">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Laura P. Jacobs</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">64</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Director Nominee</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">n/a</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following biographies
describe the skills, qualities, attributes, and experience of the nominees that led the Board of Directors and the Nominating and
Governance Committee to determine that it is appropriate to nominate these directors for election to the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Howard G. Berger,
M.D.</I> has served as President and Chief Executive Officer of RadNet and its predecessor entities since 1987. Dr. Berger received
his M.D. at the University of Illinois Medical School, is Board Certified in Nuclear Medicine and trained in an Internal Medicine
residency, as well as in a master&rsquo;s program in medical physics in the University of California system. Dr. Berger is also
the president or co-president of the entities that own BRMG. Dr. Berger brings senior business leadership skills to our Board of
Directors and deep industry knowledge derived from his nearly 40 years of experience in the development and management of RadNet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Marvin S. Cadwell</I>
has been a member of our Audit Committee since 2007, a member of our Nominating and Governance Committee since 2011 and a member
of our Compensation and Management Development Committee since 2014. Mr. Cadwell served as a director of Radiologix, Inc. between
June 2002 and November 2006, until its acquisition by RadNet. He was appointed Chairman of the Board of Radiologix in December
2002 and served as Chairman of the Nominations and Governance Committee of the Board of Radiologix. He was the Radiologix interim
Chief Executive Officer from September 2004 until November 2004. From December 2001 until November 2002, Mr. Cadwell served as
Chief Executive Officer of SoftWatch, Ltd., an Israeli based company that provided Internet software. Mr. Cadwell previously served
as a director of ChartOne, Inc., a private company that provides patient chart management services to the healthcare industry,
from 2003 until its acquisition in September 2008. Mr. Cadwell has served as an executive officer and consultant for several companies
in the healthcare industry. He brings to our Board of Directors a strong background in operating management of various organizations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>John V. Crues, III,
M.D.</I> is a world-renowned radiologist. Dr. Crues has served as our Vice President and Medical Director since 2000, and as our
Corporate Secretary since 2019. Dr. Crues received his M.D. at Harvard University, completed his internship at the University of
Southern California in Internal Medicine, and completed a residency at Cedars-Sinai in Internal Medicine and Radiology. Dr. Crues
has authored numerous publications while continuing to actively participate in radiological societies such as the Radiological
Society of North America, American College of Radiology, California Radiological Society, International Society for Magnetic Resonance
Medicine and the International Skeletal Society. Dr. Crues is also currently Co-President of Pronet Imaging Medical Group, a director
of BRMG and owns a controlling interest in four medical groups which provide professional medical services at our imaging facilities
located in New York, New York. Dr. Crues plays a significant role as a musculoskeletal specialist for many of our patients as well
as a resource for physicians providing services at our facilities. His active participation in radiological societies gives our
Board of Directors access to thought leadership in the field of radiology.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Lawrence L. Levitt</I>
has been a member of our Audit Committee since March 2005 and a member of our Nominating and Governance Committee since 2011. Mr.
Levitt has served as the Chair of our Compensation and Management Development Committee since 2007. Mr. Levitt is a certified public
accountant and received his MBA in Accounting from the University of California Los Angeles. Since 1987, Mr. Levitt has been the
President and Chief Financial Officer of Canyon Management Company, a company which manages a privately held investment fund. Mr.
Levitt brings to our Board of Directors extensive financial accounting experience and is an audit committee financial expert under
the SEC rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>David L. Swartz</I>
has been chair of our Audit Committee since 2004, has been a member of our Nominating and Governance Committee since 2007 and was
appointed as Lead Independent Director in 2011. Mr. Swartz is a certified public accountant with experience providing accounting
and advisory services to clients. Since 2010, Mr. Swartz has owned and continues to operate his own consulting services firm. Mr.
Swartz served as a member of the Board of Directors of the California State Board of Accountancy until November 2012 and previously
served as its president. Prior to 1988, Mr. Swartz served as managing partner and was on the national Board of Directors of a 50
office international accounting firm. Between 1990 and 2008, Mr. Swartz served as the managing partner of Good, Swartz, Brown &amp;
Berns LLP which was acquired by J.H. Cohn LLP in 2008. From 2008 to 2010, Mr. Swartz served as a partner at J.H. Cohn LLP. Mr.
Swartz also served as chief financial officer of a publicly held shopping center and development company from 1988 to 2000. Mr.
Swartz brings to our Board of Directors extensive public financial accounting experience and is an audit committee financial expert
under the SEC rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Ruth V. Wilson</I>
has been a member of our Board of Directors since 2019. Ms. Wilson currently serves as our Senior Vice President of Human Resources
and has served in a variety of others positions since joining us in 1994, including Manager, Director and Vice President of Human
Resources. Ms. Wilson has been an active member of our senior management since 1996. Ms. Wilson is an active member of the Society
for Human Resources Management and Professionals in Human Resources Association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Laura P. Jacobs</I>
is a director nominee. Ms. Jacobs is currently managing principal at GE Healthcare Partners, where she has worked since 1990. Prior
to her current role, Ms. Jacobs led the firm&rsquo;s healthcare management consulting business from 2015 to 2019. She is a national
expert on healthcare trends and their impact on providers, and has been involved in healthcare management for the past 40 years,
including the past 30 years with GE Healthcare Partners, advising healthcare providers regarding strategies, operations and financial
performance improvement initiatives. Ms. Jacobs has advised physician organizations, complex health systems and other healthcare
entities on strategies for growth, technology adoption and financial performance improvement. Ms. Jacobs has led strategic, financial
and operational redesign of health systems, including transforming the framework for decision-making and care delivery. Ms. Jacobs
has led the organizational and compensation redesign for provider organizations to achieve greater integration and aligned incentives.
She is a frequent speaker regarding current trends in healthcare, payer strategies, risk-based payment models, consumer expectations,
clinical integration, governance and performance optimization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a16"></A>COMPENSATION OF DIRECTORS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a17"></A>Overview of Director Compensation</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We use cash and stock
based incentive compensation to attract and retain qualified candidates to serve on our Board of Directors. In setting director
compensation, we consider the significant amount of time that our directors expend in fulfilling their duties to RadNet as well
as the skill level required by the members of our Board of Directors. The Compensation and Management Development Committee considers
and evaluates compensation arrangements and makes recommendations to the Board of Directors, which has ultimate authority to approve
such compensation. In addition, our certificate of incorporation and bylaws include indemnification provisions for our directors
and executive officers and we maintain liability insurance for our directors and executive officers. Employee directors do not
receive any compensation for their service as a director. In accordance with provisions contained in our stockholder approved 2006
Equity Incentive Plan, as amended (the &ldquo;Restated 2006 Plan&rdquo;), the maximum total compensation that can be paid to any
non-employee director in a calendar year is $500,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a18"></A>Cash Compensation Paid to Non-Employee
Board Members</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on the recommendation
of the Compensation and Management Development Committee&rsquo;s independent compensation consultant Pearl Meyer &amp; Partners
LLC (&ldquo;Pearl Meyer&rdquo;) and a review of peer group data, the Compensation and Management Development Committee and the
Board of Directors elected to keep the 2018 cash compensation structure for non-employee directors in 2019 in order to continue
to align our director compensation structure with general market practices. The 2019 cash compensation structure for non-employee
directors is set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 83%">
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 68%; text-align: justify">Annual cash compensation</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">55,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Audit Committee Chair annual cash compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">20,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: justify">Compensation and Management Development Committee Chair annual cash compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">10,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Nominating and Governance Committee Chair annual cash compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">10,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: justify">Lead Independent Director annual cash compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">10,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Committee Meeting Attendance (per meeting)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December 2019, the
Compensation and Management Development Committee and Board of Directors, noting that annual cash compensation for non-employee
directors had not been increased since January 1, 2016 and seeking to reward non-employee directors for outstanding performance,
decided to increase the annual cash compensation for each non-employee director from $55,000 to $75,000 effective as of January
1, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In April 2020, the
non-employee members of the Board of Directors, citing the evolving and uncertain impact the COVID-19 pandemic will have on RadNet&rsquo;s
operating results, cash flows and financial position, voluntarily agreed to temporarily reduce director cash compensation by 50%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Equity Compensation</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June 13, 2019,
non-employee directors each received a restricted stock award of 9,363 common shares under the Restated 2006 Plan, with a grant
date value of approximately $125,000 based on the $13.35 per-share closing price of RadNet&rsquo;s common stock. Subject to continued
service, vesting of this stock grant will occur at the end of each non-employee director&rsquo;s current term which coincides
with the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a19"></A>Nonqualified Deferred Compensation
Arrangements</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Non-employee directors
are eligible to participate in our Nonqualified Deferred Compensation Plan. No non-employee directors elected to defer any portion
of their 2019 compensation.</P>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a20"></A>Non-Employee Director Compensation</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below summarizes
the compensation received for the fiscal year ended December 31, 2019 by each of our non-employee directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: bottom; width: 35%; border-bottom: Black 1pt solid; text-align: justify; font-weight: bold">Name</TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 21%; border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Fees Earned or Paid in Cash ($)</TD>
    <TD STYLE="vertical-align: bottom; width: 4%; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 21%; border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Stock Awards ($) <FONT STYLE="font-size: 10pt"><SUP>(1)</SUP></FONT></TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 15%; border-bottom: Black 1pt solid; text-align: right; font-weight: bold">Total ($)</TD></TR>
<TR STYLE="background-color: #EEEEEE">
    <TD STYLE="vertical-align: bottom; text-align: justify">Marvin S. Cadwell</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">67,000</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">125,000</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">192,000</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; background-color: white; text-align: justify">Lawrence L. Levitt</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">77,000</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">125,000</TD>
    <TD STYLE="vertical-align: top; background-color: white; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; background-color: white; text-align: right">202,000</TD></TR>
<TR STYLE="background-color: #EEEEEE">
    <TD STYLE="vertical-align: bottom; text-align: justify">Michael L. Sherman, M.D.</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">71,000</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">125,000</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">196,000</TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom; text-align: justify">David L. Swartz</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">97,000</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">125,000</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">222,000</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_______________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: justify"><FONT STYLE="font-size: 10pt"><SUP>(1)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Reflects the restricted stock awards described above in
    &ldquo;Equity Compensation&rdquo;. In accordance with SEC rules, the amounts shown reflect the aggregate grant
    date fair value of stock awards granted in 2019 computed in accordance with FASB ASC Topic 718, calculated by multiplying the
    number of shares subject to the award by the closing price of RadNet&rsquo;s common stock on the grant date. These are not
    amounts actually paid to or necessarily realized by the non-employee director. &nbsp;As of December 31, 2019, each of the
    non-employee directors held 9,363 shares of unvested restricted stock and no stock options. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a21"></A>EXECUTIVE OFFICERS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The names of our current
executive officers, their ages as of March 31, 2020, and their positions are shown below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Name of Executive Officer</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Age</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Position</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Executive Officer Since</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 30%; text-align: justify">Howard G. Berger, M.D.</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: center">74</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 51%; text-align: justify">President, Chief Executive Officer and Chairman of the Board</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: center">1992</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">John V. Crues, III, M.D.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">70</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Vice President, Corporate Secretary and Medical Director</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2000</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: justify">Stephen M. Forthuber</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">59</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">President and Chief Operating Officer &ndash; Eastern Operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2006</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Norman R. Hames</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">64</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">President and Chief Operating Officer &ndash; Western Operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1996</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: justify">Michael M. Murdock</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">65</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Executive Vice President and Chief Development Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2007</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Mark D. Stolper</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">48</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Executive Vice President and Chief Financial Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2004</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: justify">Mital Patel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">34</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Executive Vice President of Financial Planning and Analysis</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2016</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">David J. Katz</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">56</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Executive Vice President and General Counsel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2020</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Biographical summaries
of each of our executive officers who are not also members of our Board of Directors are included below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Stephen M. Forthuber</I>
has served as an executive officer of RadNet since our acquisition of Radiologix, Inc. in 2006 and currently serves as our President
and Chief Operating Officer-Eastern Operations. He joined Radiologix in January 2000 as Regional Director of Operations, Northeast.
From July 2002 until January 2005 he served as Regional Vice President of Operations, Northeast and from February 2005 until December
2005 he was Senior Vice President and Chief Development Officer for Radiologix. Prior to working at Radiologix, Mr. Forthuber was
employed from 1982 until 1999 by Per-Se Technologies, Inc. and its predecessor companies, where he had significant physician practice
management and radiology operations responsibilities. Mr. Forthuber received a B.A. in Business Administration from the College
of William and Mary in Virginia.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Norman R. Hames</I>
has served as an executive officer of RadNet since 1996 and currently serves as our President and Chief Operating Officer-Western
Operations. Mr. Hames served on RadNet&rsquo;s Board of Directors from 2000 until his resignation in 2019. Applying his more than
20 years of experience in the industry, Mr. Hames oversees all aspects of our California facility operations. His management team,
comprised of regional directors, managers and sales managers, is responsible for responding to all of the day-to-day concerns of
our California facilities, patients, payors and referring physicians. Prior to joining RadNet, Mr. Hames was President and Chief
Executive Officer of his own company, Diagnostic Imaging Services, Inc. (which we acquired), which owned and operated 14 multi-modality
imaging facilities throughout Southern California. Mr. Hames gained his initial experience in operating imaging centers for American
Medical International, or AMI, and was responsible for the development of AMI&rsquo;s single and multi-modality imaging centers.
Mr. Hames brings business leadership skills from his experience as President and Chief Executive Officer of his own company and
has a 20-year background in the day-to-day operations of imaging centers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Michael Murdock</I>
has served as our Executive Vice President and Chief Development Officer since 2007. Mr. Murdock has spent the majority of his
career in senior financial positions with healthcare companies, ranging in size from venture-backed startups to multi-billion dollar
corporations, including positions with American Medical International and its successor American Medical Holding, Inc., a publicly
traded owner and operator of acute care facilities that was acquired by National Medical Enterprises, now Tenet Healthcare (NYSE:
THC). From 1999 through 2004, Mr. Murdock served as Chief Financial Officer of Dental One, a venture capital-backed owner and operator
of 48 dental practices in Texas, Arizona, Colorado and Utah. From 2005 to 2006, Mr. Murdock served as Chief Financial Officer of
Radiologix and joined us following the Radiologix acquisition. Mr. Murdock began his career in 1978 as an auditor with Arthur Andersen
after receiving a B.S. degree from California State University, Northridge.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I></I></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Mark D. Stolper</I>
has served as our Executive Vice President and Chief Financial Officer since July 2004 and prior to that was an independent member
of our Board of Directors. Prior to joining us, he had diverse experiences in investment banking, private equity, venture capital
investing and operations. Mr. Stolper began his career as a member of the corporate finance group at Dillon, Read and Co., Inc.,
executing mergers and acquisitions, public and private financings, and private equity investments with Saratoga Partners LLP, an
affiliated principal investment group of Dillon Read. After Dillon Read, Mr. Stolper joined Archon Capital Partners, which made
private equity investments in media and entertainment companies. Mr. Stolper also worked for Eastman Kodak, where he was responsible
for business development for Kodak&rsquo;s Entertainment Imaging subsidiary ($1.5 billion in sales). Mr. Stolper was also co-founder
of Broadstream Capital Partners, a Los Angeles-based investment banking firm focused on advising middle market companies engaged
in financing and merger and acquisition transactions. Mr. Stolper has been a member of the board of directors of RTI Surgical,
Inc. (NASDAQ: RTIX) since March 2017. He was a member of the board of directors and audit committee for On Track Innovations, Ltd.
(NASDAQ: OTIV) from December 2012 until December 2016. He was previously a member of the board of directors and audit committee
for Metropolitan Health Networks, Inc. (NYSE: MDF) from April 2010 until its sale in December 2012, was a member of the board of
directors for a privately held entertainment company providing discount ticketing services and branded event merchandising and
was Chairman of the board for a private telemedicine and eHealth provider. Mr. Stolper graduated with a liberal arts degree from
the University of Pennsylvania and a finance degree from the Wharton School. Additionally, Mr. Stolper earned a postgraduate Award
in Accounting from the University of California, Los Angeles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Mital Patel </I>has
served as our Executive Vice President of Financial Planning and Analysis since 2016. Mr. Patel has over a decade of senior healthcare
management experience. Mr. Patel started his career at Truxtun Radiology and served as part of the Management team before the acquisition
to RadNet. At Truxtun, Mr. Patel increased practice revenue, managed operation initiatives and quality compliance measures, and
managed Truxtun&rsquo;s acquisition by RadNet. Mr. Patel began his career at RadNet in 2010 where he applied his extensive healthcare
industry experience to drive profitability and market share for RadNet. Mr. Patel received a B.A. degree in Business Administration
from California State University in Bakersfield. Mr. Patel has also been very active in the community, having held board seats
in several non-profit organizations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>David J. Katz </I>has
served as our Executive Vice President and General Counsel since March 1, 2020. Mr. Katz <FONT STYLE="background-color: white">joined
RadNet from the international law firm Perkins Coie LLP, where he was a partner for 20 years, and had been in private practice
for 30 years. Mr. Katz&rsquo;s legal practice has focused on corporate finance, international transactions, mergers and acquisitions,
business planning and SEC compliance for domestic and foreign companies. Mr. Katz has also served as a Los Angeles County Sheriff
Reserve Deputy since 1990, and is a two-time Medal of Valor recipient from the Los Angeles County Sheriff&rsquo;s Department.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our officers are elected
annually and serve at the discretion of the Board of Directors. There are no family relationships among any of our executive officers
and directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a22"></A>COMPENSATION COMMITTEE REPORT*</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation and
Management Development Committee of the Board of Directors is comprised of independent non-employee directors and operates pursuant
to a written charter. A copy of the charter can be viewed by visiting our website at <I>www.radnet.com</I> and clicking on &ldquo;Investor
Relations&rdquo; and then on &ldquo;Corporate Governance.&rdquo; The Compensation and Management Development Committee is responsible
for setting and overseeing the administration of the policies governing annual compensation of RadNet&rsquo;s executive officers.
The Compensation and Management Development Committee reviews the performance and compensation levels for executive officers, including
the Chief Executive Officer, and sets salary levels.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation and
Management Development Committee has reviewed and discussed with RadNet&rsquo;s management the &ldquo;Compensation Discussion and
Analysis&rdquo; included below in this Proxy Statement. Based upon that review and analysis, the Compensation and Management Development
Committee unanimously recommended to the Board of Directors that the &ldquo;Compensation Discussion and Analysis&rdquo; be included
in this Proxy Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Submitted by the Compensation
and Management Development Committee:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 50%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lawrence L. Levitt, Chair</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Marvin S. Cadwell</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Michael L. Sherman, M.D.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">David L. Swartz</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">_______________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">* The material in this report is not &ldquo;soliciting
material,&rdquo; is not deemed filed with the SEC and is not to be incorporated by reference into any of our filings under the
Securities Act or the Exchange Act whether made before or after the date of this Proxy Statement and irrespective of any general
incorporation language therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a23"></A>COMPENSATION DISCUSSION AND ANALYSIS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Compensation Discussion
and Analysis explains the guiding principles and practices upon which our executive compensation program is based and the compensation
paid to our 2019 Named Executive Officers (who consist of our principal executive officer, principal financial officer and our
three other highest compensated executive officers in 2019):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Howard G. Berger, M.D.
&ndash; President and Chief Executive Officer (our principal executive officer)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mark D. Stolper &ndash;
Executive Vice President and Chief Financial Officer (our principal financial officer)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Norman R. Hames &ndash;
President and Chief Operating Officer &ndash; Western Operations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Stephen M. Forthuber
&ndash; President and Chief Operating Officer &ndash; Eastern Operations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mital Patel &ndash; Executive Vice
President of Financial Planning and Analysis</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our executive compensation
program is designed to attract, retain and motivate talented executive officers who are capable of providing leadership, vision
and execution necessary to achieve our business objectives. We actively seek to foster an environment that aligns the interests
of our Named Executive Officers with the creation of stockholder value through our equity compensation program. We believe the
compensation paid to our Named Executive Officers for 2019 appropriately reflects and rewards their contribution to our performance.
Since it describes our executive compensation program for 2019, this Compensation Discussion and Analysis does not address the
impact of the coronavirus (or COVID-19) on the global economy, our business and financial results, or our executive compensation
for 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">RadNet had an exceptional
year in 2019. Our 2019 revenue of $1.154 billion reflected an impressive 18.4% increase over 2018 and those revenues helped generate
$14.8 million of net income. During 2019 we continued our <FONT STYLE="background-color: white">strong organic growth, effectively
controlled expenses throughout the year, and made significant progress towards furthering all aspects of our business strategy.
With respect to acquisitions, we purchased Kern Radiology, an operator of five imaging centers in Bakersfield, California, as well
as completed transactions in West Hills, California, Islip, New York and Central New Jersey. We established our second California-based
joint venture with Dignity Health in Ventura County and entered into discussions with several health systems to establish additional
joint ventures. Additionally, we began to pursue applications for artificial intelligence by creating a division within RadNet
focused on developing algorithms for image interpretation and for streamlining certain business processes. We believe that this
strong performance in 2019 was directly related to the performance of our executive management. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a24"></A>Compensation Philosophy</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following principles
influence and guide the compensation decisions of the Compensation and Management Development Committee:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><I>Our
Management Team is Integral to our Success. </I>At the core of our compensation philosophy is the guiding belief that our management
team is an integral component to RadNet&rsquo;s continued success. Equity compensation and cash bonuses are determined in December
and paid at the beginning of the fiscal year with the goal of continuing to retain and incentivize our Named Executive Officers
to achieve or exceed the strategic initiatives set for the upcoming year.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><I>Compensation
Decisions Should Promote the Interests of Stockholders. </I>Compensation should create incentives for management to achieve strong
short-term (annual) performance in a manner that supports and ensures our long-term success and profitability. The Compensation
and Management Development Committee believes that stock option and restricted stock awards (or restricted stock units (&ldquo;RSUs&rdquo;))
create long-term incentives that align the interests of management with the long-term interests of stockholders.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><I>Compensation
Should Reflect Position and Responsibility. </I>Total compensation and accountability should generally increase with position
and responsibility. Consistent with this philosophy: (1) total compensation is higher for individuals with greater responsibility
and greater ability to influence RadNet&rsquo;s achievement of targeted results and strategic initiatives; and (2) equity-based
compensation is higher for persons with higher levels of responsibility, making a significant portion of their total compensation
dependent on long-term stock appreciation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><I>Internal
Pay Equity. </I>We have not established a formal policy regarding the ratio of total compensation of the Chief Executive Officer
to that of the other officers, but the Compensation and Management Development Committee believes that internal pay equity is
an important factor to be considered in establishing compensation for our Named Executive Officers, and reviews compensation levels
to ensure that appropriate pay equity exists.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>&nbsp;</I></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><I>Compensation
Should be Reasonable and Responsible. </I>It is essential that our overall compensation levels be sufficiently competitive to
attract and retain talented leaders and motivate those leaders to achieve superior results. At the same time, we believe that
compensation should be set at responsible levels and the Compensation and Management Development Committee periodically reviews
market information from external sources or advisors to determine appropriate levels. Our executive compensation programs are
intended to be consistent with our focus on controlling costs.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><I>Compensation
Disclosures Should be Clear and Complete. </I>The Compensation and Management Development Committee and management believe that
all aspects of executive compensation should be clear, comprehensible and promptly disclosed in plain English. The Compensation
and Management Development Committee and management believe that compensation disclosures should provide all of the information
necessary to permit stockholders to understand our compensation philosophy, our compensation-setting process and how and how much
our executives are paid.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a25"></A>Board and Committee Process</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>The Role of the Compensation and Management
Development Committee</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board of Directors
has delegated to the Compensation and Management Development Committee the authority to approve all compensation and awards to
Named Executive Officers. With respect to equity compensation awarded to the Named Executive Officers and others, the Compensation
and Management Development Committee acts as the administrator under the Restated 2006 Plan, and has the authority under that plan
to grant equity compensation awards, including restricted stock, RSUs and stock options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Compensation and
Management Development Committee meets as often as necessary to perform its duties and responsibilities. The Committee meets with
its compensation consultant and, as applicable, executive management, including our Chief Executive Officer, and conducts meetings
in executive session. The Compensation and Management Development Committee meets in executive session each year to: (1) evaluate
the performance of the Named Executive Officers, (2) set the annual compensation of the Named Executive Officers, and (3) consider
and approve any grants of equity incentive compensation to the Named Executive Officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation and
Management Development Committee has ultimate authority, including delegated authority over all aspects of Named Executive Officer
compensation, including the base salary for each Named Executive Officer and the overall compensation of the Chief Executive Officer.
The Compensation and Management Development Committee has, for several years, adhered to an informal policy pursuant to which each
year the Committee determines, based on a number of factors, the aggregate maximum value of cash bonus, restricted stock (or RSUs)
and stock options that may be awarded to each Named Executive Officer. The Compensation and Management Development Committee has
delegated to the Chief Executive Officer the authority to allocate the exact amount of such awards and the combination of cash
and equity for the other Named Executive Officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>The Role of Management in the Compensation-Setting
Process</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Management&rsquo;s
role in the compensation-setting process, includes the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">to establish the operating budget approved by the Board of Directors, which forms the basis for evaluating corporate achievements and the achievements of the divisions our Named Executive Officers manage that are taken into consideration when evaluating compensation levels for Named Executive Officers; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">to make recommendations to the Compensation and Management Development Committee on salary levels and stock option and restricted stock awards (or RSUs); and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">our Chief Executive Officer allocates the amount of cash bonus, restricted stock (or RSUs) and stock option amounts to be awarded to our Named Executive Officers (other than himself), in all cases subject to the guidelines and limitations established by the Compensation and Management Development Committee.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Management also prepares
information for each Compensation and Management Development Committee meeting. Our Chief Executive Officer also participates in
committee meetings at the request of the Compensation and Management Development Committee to provide, among other things:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">background information regarding RadNet&rsquo;s strategic objectives; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">his evaluation of the performance of the Named Executive Officers, including accomplishments, and areas of strength and weakness.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>The Role of the Compensation Consultant
</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under its charter,
the Compensation and Management Development Committee is granted the authority to retain outside advisors and compensation consultants.
The Compensation and Management Development Committee has retained the compensation consulting firm Pearl Meyer to serve as its
independent outside compensation consultant and provide compensation analysis and advice since 2016. Pearl Meyer provides the following
services with respect to compensation determinations:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Executive compensation benchmarking and framework;</TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Assess market trends of non-employee director compensation;</TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Review of market compensation practices and trends;</TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Annual incentive plan and equity award design;</TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Advice on merit increases, target bonuses and equity award levels;</TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Legislative and regulatory updates;</TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Attendance at certain Compensation and Management Development Committee meetings.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pearl Meyer also attends
certain Compensation and Management Development Committee meetings in person or by telephone, including executive sessions as requested,
and consults with the Compensation and Management Development Committee Chair between meetings. Pearl Meyer also reviewed and commented
on this executive compensation disclosure and the Named Executive Officer and director compensation tables contained in this Proxy
Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As part of the selection
and retention process, the Compensation and Management Development Committee analyzes the independence of Pearl Meyer under SEC
and Nasdaq Rules. Pearl Meyer reports directly to the Compensation and Management Development Committee and performs no other work
for RadNet besides rendering compensation consulting services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with
its charter, the Compensation and Management Development Committee analyzed whether the work of Pearl Meyer as a compensation consultant
has raised any conflict of interest, taking into consideration the following factors: (i) the provision of other services to RadNet
by Pearl Meyer; (ii) the amount of fees from RadNet paid to Pearl Meyer as a percentage of the firm&rsquo;s total revenue; (iii)
Pearl Meyer&rsquo;s policies and procedures that are designed to prevent conflicts of interest; (iv) any business or personal relationship
of Pearl Meyer or the individual compensation advisors employed by the firm with an executive officer of RadNet; (v) any business
or personal relationship of the individual compensation advisors with any member of the Compensation and Management Development
Committee; and (vi) any stock of RadNet owned by Pearl Meyer or the individual compensation advisors employed by the firm. The
Compensation and Management Development Committee has determined based on its analysis of the above factors, that the work of Pearl
Meyer and the individual compensation advisors employed by Pearl Meyer as compensation consultants to RadNet has not created a
conflict of interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>The Role of Peer Companies and Benchmarking</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation and
Management Development Committee reviews a peer group of companies (&ldquo;Peer Group&rdquo;) recommended by Pearl Meyer in order
to assess the competitiveness of our executive officer compensation level and structure. The composition of the Peer Group is reviewed
each year. For 2019 and 2020, the Peer Group includes the following companies:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: #E7E6E6">
    <TD STYLE="width: 40%; text-align: left"><FONT STYLE="font-size: 10pt">AAC Holdings, Inc.</FONT></TD>
    <TD STYLE="width: 26%; text-align: left"><FONT STYLE="font-size: 10pt">Amedisys Inc.</FONT></TD>
    <TD STYLE="width: 34%; text-align: left"><FONT STYLE="font-size: 10pt">American Renal Associates Holdings, Inc.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Chemed Corp.</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Civitas Solutions, Inc.</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">The Ensign Group, Inc.</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #E7E6E6">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Healthways Inc. (changed to Tivity Health, Inc.)</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">LHC Group, Inc.</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">National Healthcare Corp.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Premier, Inc.</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Providence Service Corp.</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Surgery Partners, Inc.</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #E7E6E6">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">US Physical Therapy Inc.</FONT></TD>
    <TD STYLE="padding-left: 0.1in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 0.1in; text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following selection
criteria was established to identify companies for inclusion in the Peer Group:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">U.S. publicly traded companies with annual revenue approximately one-third to two times RadNet&rsquo;s
annual revenue</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Primary operations in the healthcare facility and services industry</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a26"></A>Elements of Executive Compensation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Base Salary</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We seek to establish
a base salary compensation level that appropriately recognizes each Named Executive Officer&rsquo;s achievements and contributions.
Base salary also provides executives with a secure level of monthly income that is not at risk, and our Compensation and Management
Development Committee believes that this gives our Named Executive Officers the ability to focus on the longer term and avoid the
urgency that could otherwise encourage a Named Executive Officer to take unnecessary risks. In determining base salaries, our Compensation
and Management Development Committee considers the Named Executive Officer&rsquo;s qualifications and experience, scope of responsibilities
and future potential, the executive&rsquo;s ability to influence RadNet&rsquo;s achievements of targeted results and strategic
initiatives, the goals and objectives established for the Named Executive Officer, the Named Executive Officer&rsquo;s past performance,
the general pay practices at other companies in our Peer Group, internal pay equity and the tax deductibility of base salary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Discretionary Cash Bonuses</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In recent years, in
lieu of increasing base salary compensation, the Compensation and Management Development Committee has elected to supplement base
salary and equity based compensation with discretionary cash bonus awards generally paid in the beginning of the fiscal year. These
discretionary cash bonuses are awarded with the goal of continuing to retain and incentivize our Named Executive Officers to achieve
or exceed the strategic initiatives set for the upcoming year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Equity Based Compensation</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that equity
compensation is the most effective means of creating a long-term link between the compensation provided to officers and other key
management personnel with gains realized by our stockholders. The Compensation and Management Development Committee uses equity
awards, including restricted stock, RSUs and stock options, as a long-term incentive vehicle because:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">restricted stock, RSUs and stock options align the interests of executives with those of our stockholders, support a pay-for-performance culture, foster employee stock ownership and focus the management team on increasing value for our stockholders; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the vesting period encourages executive retention and the creation of stockholder value.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We use a mix of restricted
stock, RSUs and stock options for equity compensation grants to the Named Executive Officers. In determining the maximum number
of shares of restricted stock, RSUs and stock options to be granted to Named Executive Officers, the Compensation and Management
Development Committee considers the individual&rsquo;s position, scope of responsibility, ability to affect profits and stockholder
value and the individual&rsquo;s historic and recent performance, the value of the equity awards in relation to other elements
of total compensation, internal pay equity and market competitiveness. The Chief Executive Officer considers similar factors when
allocating the number of shares of restricted stock, RSUs and stock options to be granted to the senior executive officers, within
the limitations set by the Compensation and Management Development Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have one long-term
equity incentive plan&ndash;the Restated 2006 Plan&mdash;which was most recently approved by our stockholders at our annual stockholders
meeting on June 8, 2017. Unless terminated earlier, the Restated 2006 Plan will terminate on March 9, 2027. The Restated 2006 Plan
permits the discretionary award of incentive stock options (ISOs), nonqualified stock options (NSOs), stock appreciation rights
(SARs), restricted stock, RSUs, and cash awards. Employees, consultants and Board members of RadNet and certain of our affiliated
companies are eligible to receive awards under the Restated 2006 Plan. As of March 15, 2020, approximately 7,400 employees (including
7 executive officers) and 4 non-employee directors were eligible to participate in the Restated 2006 Plan. Our Restated 2006 Plan
has provided the principal method for our Named Executive Officers (other than our Chief Executive Officer) to acquire equity or
equity linked interests in RadNet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt">The Compensation and
Management Development Committee administers the Restated 2006 Plan and, among other things, selects individuals to whom awards
may be granted, determines the type of award as well as the number of shares of common stock to be covered by each award, determines
the terms and conditions of any awards, including performance goals (if any) and their degree of satisfaction and interprets the
terms and provisions of the Restated 2006 Plan and any stock award issued under the Restated 2006 Plan. However, the exercise prices
of outstanding stock options and SARs may not be lowered or reduced without the approval of our stockholders. In addition, the
Restated 2006 Plan limits grants to any non-employee director so that total compensation in any calendar year in the aggregate
does not exceed $500,000. That limit includes all cash compensation such as annual retainers and other fees (whether or not granted
under the Restated 2006 Plan) plus the aggregate grant date fair market value (computed as of the date of grant in accordance with
applicable financial accounting rules) of all awards issued under the Restated 2006 Plan or under any other incentive plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of April 6, 2020,
there remained 2,038,055 shares available under the Restated 2006 Plan for future issuance. Shares underlying forfeited or terminated
awards, or awards which are entirely settled with cash or which are repurchased by RadNet for a repurchase price that does not
exceed what the grantee paid for such shares, will become fully available again for issuance under the Restated 2006 Plan. No fractional
shares may be issued under the Restated 2006 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Additional Benefits</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our executive officers,
including our Named Executive Officers, participate in other employee benefit plans generally available to all employees on the
same terms as similarly situated employees. Perquisites to our Named Executive Officers are not a material element of our compensation
program. We pay the premiums for our Named Executive Officers&rsquo; coverages under our health and life insurance plans and all
of our Named Executive Officers are provided a monthly car allowance. We also maintain a Split Dollar Life Insurance Plan pursuant
to which we have corporate owned life insurance (&ldquo;COLI&rdquo;) policies on our key management employees including our Named
Executive Officers. These COLI policies would, upon the insured&rsquo;s death, pay death benefits proceeds to the insured&rsquo;s
beneficiaries while RadNet would then receive any excess death benefit proceeds along with any remaining cash surrender value of
the COLI policy. Each Named Executive Officer has executed a participation agreement with RadNet under the Split Dollar Life Insurance
Plan and this agreement specifies the amount of death benefit proceeds and the beneficiaries of this life insurance arrangement.
Additionally, we provide matching 401(k) contributions for our employee participants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Change in Control and Severance Arrangements</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As an inducement to
attract and retain qualified executive officers, certain benefits are provided if the Named Executive Officer&rsquo;s employment
is terminated under certain circumstances, including termination following a change in control of RadNet. Certain of our Named
Executive Officers&rsquo; employment agreements provide for them to receive severance payments to include one or more times their
annual base salary and full acceleration of vesting for all then-unvested shares subject to restricted stock awards, RSUs, stock
option awards or warrants upon the date of termination of employment outside of a change in control of RadNet. Certain of our Named
Executive Officers&rsquo; employment agreements provide that if, in anticipation of or during the 24 months following a change
in control of RadNet, a Named Executive Officer&rsquo;s employment is terminated without &ldquo;Cause&rdquo; or Named Executive
Officer resigns for &ldquo;Good Reason&rdquo; (each as defined in the Restated 2006 Plan), then all then-unvested shares subject
to restricted stock awards, RSUs, stock option awards or warrants become fully vested upon the date of termination of employment.
And certain of our Named Executive Officers&rsquo; employment agreements provide that, in the event of a change in control of RadNet,
all then-unvested shares subject to restricted stock awards, RSUs, stock option awards or warrants become fully vested upon the
date of the change in control. None of our Named Executive Officers are eligible for gross-up payments to cover excise taxes in
connection with a change in control transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Nonqualified Deferred Compensation Arrangements</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We maintain a Nonqualified
Deferred Compensation Plan (the &ldquo;Deferred Compensation Plan&rdquo;) which is administered by the Compensation and Management
Development Committee. The Named Executive Officers, the members of the Board of Directors, and other executives or highly compensated
employees of RadNet or designated affiliated entities (collectively, &ldquo;Participants&rdquo;) who are selected by the Compensation
and Management Development Committee are eligible to participate in the Deferred Compensation Plan. Participants have the opportunity
to voluntarily elect to defer the timing of payment of base salary, incentive compensation and/or stock awards. The Compensation
and Management Development Committee determines which forms of compensation are eligible for deferral and can prescribe limits
on the amount of deferrals. It may also, in its discretion, credit a Participant&rsquo;s account with a contribution amount from
RadNet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cash-based deferrals
may also accrue notional investment returns based on the performance of one or more measurement funds selected by RadNet and in
which the Participant may elect to have portions of his/her cash account hypothetically invested. RadNet stock grant deferrals
will be settled on a one-for-one basis with RadNet common shares (or their cash equivalent). The Deferred Compensation Plan is
not funded; payments are made out of RadNet&rsquo;s general assets and Participants are unsecured general creditors of RadNet with
respect to deferred amounts. However, RadNet may, in its discretion, establish a &ldquo;rabbi trust&rdquo; to provide a source
of funds for meeting its financial obligations under the Deferred Compensation Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Participants generally
must submit their elections to defer compensation before the calendar year in which compensation is earned (except that Participants
can make a deferral election within 30 days of their initial eligibility to participate in the Deferred Compensation Plan). Once
such an election is timely made, the deferral remains effective for subsequent years unless the participant affirmatively terminates
the deferral. Settlement of deferred amounts will be affected in accordance with the Deferred Compensation Plan and the applicable
deferral election and generally will be paid in either a lump sum or a series of annual installments after the applicable distribution
date. Deferred compensation amounts can be paid out on an accelerated basis under certain circumstances including a change in control
of RadNet. The aggregate amount that could potentially be paid out under the Deferred Compensation Plan is presently indeterminable
and will depend on the amounts and types of deferrals along with the performance of the hypothetical investments and RadNet stock
value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Deferred Compensation
Plan is intended to be a &ldquo;top-hat&rdquo; plan and is governed by the laws of the state of Delaware except to the extent preempted
by The Employee Retirement Income Security Act of 1974 (&ldquo;ERISA&rdquo;). It is intended that the Deferred Compensation Plan
and any payments thereunder comply with Internal Revenue Code (&ldquo;Code&rdquo;) Section 409A, which governs the federal income
taxation of nonqualified deferred compensation. The Deferred Compensation Plan will remain in effect until terminated by RadNet,
but deferred amounts may still, in certain circumstances, remain outstanding in accordance with the applicable deferral elections
after termination.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a27"></A>Pay Ratio Disclosure</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under SEC rules we
are required to disclose the ratio of our median employee&rsquo;s total annual compensation to the total annual compensation of
Dr. Berger, our principal executive officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In determining the
median employee, we prepared a list of all employees as of December 31, 2017. We excluded 76 employees based overseas in Canada
and Hungary, because they represented 1.0% of total employees and their exclusion did not have a material effect on the median
calculation. We do not grant equity compensation awards widely to our employees, and consequently determined that annual gross
wages is an appropriate compensation metric to utilize. We selected our median employee based on the annual gross wages reflected
in our payroll records in 2017, which includes part-time, temporary and international employees (we do not have any seasonal employees).
Because the median employee we initially identified had anomalous compensation characteristics, another employee with substantially
similar compensation based on the compensation methodology used to identify the originally identified median employee was substituted
for such employee as our median employee for 2017. There has been no material change in our employee base or the compensation of
the median employee since 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For 2019, the pay ratio
calculation is as follows, showing that for 2019, the PEO&rsquo;s total annual compensation was 86 times that of the median of
the total annual compensation of all employees other than the PEO:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 86%; text-align: justify">Median Employee total annual compensation</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">35,338</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Dr. Berger (&#8223;PEO&rdquo;) total annual compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3,048,401</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: justify">Ratio of PEO to Median Employee Compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">86:1</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because the SEC rules
for identifying the median employee and calculating the pay ratio based on that employee&rsquo;s total annual compensation allow
companies to use a variety of methodologies, to apply certain exclusions and to make reasonable estimates and assumptions that
reflect their employee populations and compensation practices, the pay ratio reported by other companies may not be comparable
to our pay ratio, as other companies may utilize different methodologies, exclusions, estimates and assumptions in calculating
their pay ratios. These companies may also operate in different industries and different geographic locations, be of a different
size, have different revenues, earnings and market capitalization and be subject to different regulation than RadNet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a28"></A>2019 Compensation Determinations</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2019, the Compensation
and Management Development Committee, with the assistance of Pearl Meyer as its independent compensation consultant, determined
that the core philosophies, policies and approaches used in 2017 and 2018 remained appropriate for the 2019 compensation determinations.
The Compensation and Management Development Committee again elected to set the maximum award for any discretionary cash bonus or
restricted stock awards (or RSUs) and stock options to be granted to each of the Named Executive Officers (other than the Chief
Executive Officer) to equal, in the aggregate, approximately 100% of such Named Executive Officer&rsquo;s annual base salary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In January 2019 subject
to these guidelines set by the Compensation and Management Development Committee, Dr. Berger, as the Chief Executive Officer, elected
to allocate the maximum cash bonus, restricted stock (or RSUs) and stock option amounts to Messrs. Stolper, Forthuber, Hames and
Patel as set forth in the table below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 77%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: bottom; width: 20%; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 18%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Cash Bonus</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 18%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Number of Shares of Restricted Stock/RSUs</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 18%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Number of Shares Subject to Option Grants</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #F2F2F2">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Stephen Forthuber</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$275,000</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">25,158</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">25,158</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Norman Hames</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$275,000</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">25,158</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">25,158</FONT></TD></TR>
<TR STYLE="background-color: #EEEEEE">
    <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">Mark Stolper</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">$237,500</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">21,729</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">21,729</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">Mital Patel</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">$187,500</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">17,154</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">17,154</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The grant date of the
restricted stock awards was made effective January 7, 2019 and the closing price of a share of Company common stock on that date
was $10.93. Each restricted stock grant vests in three equal annual increments with the first installment vesting on the grant
date. Mr. Stolper&rsquo;s grant of 21,729 shares was in the form of a 19,828 RSU grant, because he had timely elected to defer
such equity grant compensation under the Deferred Compensation Plan, and a 1,901 restricted stock award grant that was transferred
to his former spouse pursuant to a domestic relations order.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the Compensation
and Management Development Committee and Dr. Berger also elected to grant stock options to each Named Executive Officer with the
number of shares subject to the option equal to the same number of shares of restricted stock granted, as shown above. The stock
options all have a ten year maximum term and a per share exercise price equal to the closing price ($10.93) of RadNet&rsquo;s common
stock on the date of grant (January 7, 2019) and vest in equal one-third increments on each anniversary of the grant date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation and
Management Development Committee elected not to grant any equity awards to Dr. Berger in 2019. The Compensation and Management
Development Committee determined that the equity interest in RadNet owned by HFB Heirs&rsquo; Trust II, an irrevocable trust for
the benefit of Dr. Berger&rsquo;s children, was sufficient to align Dr. Berger&rsquo;s interests with other stockholders. As an
alternative to an equity award, and consistent with its actions in 2018, the Compensation and Management Development Committee
in December 2019 awarded Dr. Berger a discretionary cash bonus of $2,000,000, which was paid in January 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In February 2019, the
Compensation and Management Development Committee determined to provide for full acceleration of vesting for all then-unvested
shares underlying restricted stock awards, RSUs and stock option grants under the Restated 2006 Plan and the Deferred Compensation
Plan upon termination of a participant due to his/her death or Disability, as defined in the Restated 2006 Plan. This change applies
to all outstanding and future equity compensation awards held by any service provider.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a29"></A>2019 Stockholder Advisory Vote on
Executive Compensation</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In June 2019, over
97% of the stockholder votes (including those that abstained and excluding broker non-votes) were cast &ldquo;FOR&rdquo; the stockholder
advisory vote regarding our Named Executive Officers&rsquo; compensation, an increase from the over 95% of stockholder votes cast
&ldquo;FOR&rdquo; the same stockholder advisory vote in June 2018. The Compensation and Management Development Committee carefully
considered these results and a variety of other information, including the advice of Pearl Meyer, in determining compensation structure
and amounts for 2020, which generally is similar to what was done for 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a30"></A>2020 Compensation Determinations</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation and
Management Development Committee, with advice from Pearl Meyer, elected to increase base salaries for the Named Executive Officers
in 2020 in order attain a greater level of parity with the Peer Group, as set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 72%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: bottom; width: 30%; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 20%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">2019 Salary</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 20%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">2020 Salary</FONT></TD></TR>
<TR STYLE="background-color: #F2F2F2">
    <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">Howard Berger, M.D.</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$1,000,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$1,200,000</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">Stephen Forthuber</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$550,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$600,000</FONT></TD></TR>
<TR STYLE="background-color: #F2F2F2">
    <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">Norman Hames</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$550,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$600,000</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">Mark Stolper</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$475,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$525,000</FONT></TD></TR>
<TR STYLE="background-color: #F2F2F2">
    <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">Mital Patel</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$425,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$500,000</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on the competitive
analysis provided by Pearl Meyer, the Compensation and Management Development Committee established the maximum amounts for the
discretionary cash bonus and restricted stock (or RSU) grants. The maximum cash bonus and restricted stock grant amounts are to
equal, in the aggregate, approximately 100% of such Named Executive Officer&rsquo;s annual base salary paid in 2019. The maximum
amounts for discretionary cash bonuses, restricted stock (or RSU) grants and stock options in 2020 are intended to support retention
and to continue to align the interests of our Named Executive Officers with the creation of stockholder value. On January 6, 2020,
in accordance with the Compensation and Management Development Committee&rsquo;s authorization, Dr. Berger elected to award the
maximum amounts for any discretionary cash bonus, restricted stock (or RSU) and stock option grants to each of the Named Executive
Officers (other than the Chief Executive Officer), as set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 77%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: bottom; width: 20%; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: bottom; width: 18%; text-align: center"><FONT STYLE="font-size: 10pt">Cash Bonus</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: top; width: 18%; text-align: center"><FONT STYLE="font-size: 10pt">Number of Shares of Restricted Stock/RSUs</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: top; width: 18%; text-align: center"><FONT STYLE="font-size: 10pt">Number of Shares Subject to Option Grants</FONT></TD></TR>
<TR STYLE="background-color: #F2F2F2">
    <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">Stephen Forthuber</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">$275,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">13,461</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">13,461</FONT></TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">Norman Hames</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">$275,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">13,461</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">13,461</FONT></TD></TR>
<TR STYLE="background-color: #EEEEEE">
    <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">Mark Stolper</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">$237,500</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">11,625</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">11,625</FONT></TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 10pt">Mital Patel</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">$212,500</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">10,401</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">10,401</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Stolper&rsquo;s
stock grant (net of the portion transferred to his former spouse) was in the form of a RSU because he had timely elected to defer
such equity grant compensation under the Deferred Compensation Plan. The restricted stock and RSU grants vest annually in equal
one-third increments with the first installment vesting on the grant date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on recommendations
presented by Pearl Meyer and in an effort to attain a greater level of parity with the Peer Group, the Compensation and Management
Development Committee also elected to grant to each Named Executive Officer a stock option (as shown above) covering the same number
of shares of restricted stock (or RSUs) contemporaneously granted to such Named Executive Officer. The stock options have a maximum
ten year term and an exercise price equal to the closing price ($20.43) of RadNet&rsquo;s common stock on the date of grant (January
6, 2020) and in the aggregate vest equally in one-third increments on each of the first three anniversaries of the grant date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Consistent
with prior years, </FONT>the Compensation and Management Development Committee elected not to grant any equity awards to Dr. Berger
in 2020. As an alternative to an equity award, and consistent with its actions in 2019, the Compensation and Management Development
Committee awarded Dr. Berger a discretionary cash bonus of $2,000,000, which was paid in January 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In April 2020, RadNet&rsquo;s
Named Executive Officers, citing the evolving and uncertain impact the COVID-19 pandemic will have on RadNet&rsquo;s operating
results, cash flows and financial position, voluntarily agreed to temporarily reduce base salaries for all Named Executive Officers
by 50%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a31"></A>Taxes, Risks and other Considerations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Tax Deductibility of Compensation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 162(m) of the
Internal Revenue Code generally places a $1 million limit on the amount of compensation a publicly held company can deduct in any
tax year on compensation paid to &ldquo;covered employees.&rdquo; Prior to the passage of the 2017 Tax Cuts and Jobs Act, performance-based
compensation paid to our &ldquo;covered employees,&rdquo; such as annual cash incentives and performance-based stock grants, was
generally excluded from this $1 million deduction limit. As a result of changes in the tax law, this previously-available exclusion
for performance-based compensation is generally no longer available after 2017. The Compensation and Management Development Committee
considers tax deductibility as one of many factors in determining executive compensation, including the impact of these tax law
changes. However, the Compensation and Management Development Committee believes that in certain circumstances factors other than
tax deductibility take precedence when determining the forms and levels of executive compensation most appropriate and in the best
interests of us and our stockholders. Thus, executive compensation arrangements may not be tax deductible or, if initially intended
to be tax deductible, may not actually receive this treatment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Risk Considerations in Our Compensation
Programs</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Compensation and
Management Development Committee reviews the concept of risk as it relates to our compensation program and does not believe our
compensation program encourages excessive or inappropriate risk taking. The Committee believes our compensation programs strike
a balance between providing secure compensation (base salaries) as well as appropriate short- and long-term incentives, such that
our executive officers are not encouraged to take unnecessary or excessive risks.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Stock Ownership</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We structure our pay
to consist of primarily fixed compensation with base salary in cash and non-cash long-term incentive programs. <FONT STYLE="background-color: white">Although
we do not have requirements or guidelines specifying amounts of ownership of RadNet common stock for our Named Executive Officers,
we do promote and encourage the aligning of their interests with those of our stockholders by providing them with significant equity
awards. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Clawback Policy</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board of Directors
has adopted a Policy on Recoupment of Compensation or &ldquo;Clawback Policy&rdquo; that is intended to deter both financial/accounting
irregularities with respect to RadNet&rsquo;s financial statements and also misconduct by senior executives. The Clawback Policy
is generally administered by the Compensation and Management Development Committee although the Board of Directors may administer
the policy or designate another committee to serve in such role, and may also act in conjunction with the Audit Committee. The
policy applies to RadNet&rsquo;s officers and other designated key employees (collectively, &ldquo;Senior Executives&rdquo;) during
their employment and continuing until the third anniversary of their cessation in serving as a Senior Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Clawback
Policy, if the RadNet restates any financial statements previously filed with the SEC (other than due to a change in accounting
policy), then the Compensation and Management Development Committee (or other designated committee) can take certain actions to
recoup performance-based compensation from the Senior Executives that exceeded the amount that would have been paid under the restated
financial results, including the cancellation of equity compensation awards. Performance-based compensation that was paid or earned
more than three years prior to the date of discovery of the financial/accounting irregularity would generally not be subject to
recoupment under the Clawback Policy. A Senior Executive that is determined to have committed &ldquo;Misconduct&rdquo; (as defined
under the Clawback Policy) is subject to additional measures including recoupment or cancellation or reimbursement of incentive
compensation, adjustment of future compensation, and/or disciplinary actions including termination of employment (with concurrence
of the Board of Directors).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a32"></A>EXECUTIVE COMPENSATION TABLES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a33"></A>Summary Compensation Table</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table,
footnotes and related narrative summarizes the total compensation paid to or earned by each of our Named Executive Officers for
2019, 2018 and 2017:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><B>Name and Principal Position</B></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><B>Year</B></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><B>Salary <BR>
($)</B></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><B>Bonus ($)</B></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><B>Stock Awards ($)<SUP>(1)</SUP></B></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><B>Option Awards ($)<SUP>(1)</SUP></B></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><B>All Other Compensation ($)<SUP>(2)</SUP></B></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><B>Total <BR>
($)</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 31%">Howard G. Berger, M.D.</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: center">2019</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: center">1,000,000</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right">2,000,000</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right">--</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right">--</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 12%; text-align: right">48,401</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right">3,048,401</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>President and Chief Executive Officer</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2018</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1,000,000</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">2,000,000</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">--</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">--</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">11,862</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">3,011,862</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>(principal executive officer) <SUP>(3)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2017</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">700,000</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1,200,000</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">--</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">--</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">10,570</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1,910,570</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Mark D. Stolper</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2019</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">475,000</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">237,500</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">237,498</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">113,877</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">25,608</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1,089,483</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Executive Vice President and Chief </TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2018</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">475,000</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">237,500</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">237,492</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">124,608</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">31,819</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1,106,419</TD></TR>
<TR STYLE="background-color: rgb(238,238,238)">
    <TD STYLE="vertical-align: bottom">Financial Officer (principal <BR>
&nbsp;&nbsp;&nbsp;financial officer)</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">2017</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">475,000</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: right">237,500</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: right">237,500</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: right">129,583</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: right">26,685</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: right">1,106,268</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Stephen M. Forthuber</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2019</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">550,000</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">275,000</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">274,977</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">131,842</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">33,435</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1,265,254</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>President and Chief Operating </TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2018</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">550,000</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">275,000</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">274,998</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">144,287</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">17,750</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1,262,035</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Officer &ndash; Eastern Operations</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2017</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">550,000</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">237,500</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">237,500</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">129,583</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">27,057</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1,181,640</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Norman R. Hames</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2019</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">550,000</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">275,000</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">274,977</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">131,842</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">14,873</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1,246,712</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>President and Chief Operating </TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2018</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">550,000</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">275,000</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">274,998</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">144,287</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">7,625</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1,251,910</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Officer &ndash; Western Operations</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2017</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">550,000</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">237,500</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">237,500</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">129,583</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">16,000</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1,170,583</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Mital Patel</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2019</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">425,000</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">187,500</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">187,493</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">89,897</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">33,988</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">923,988</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Executive Vice President of</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2018</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">375,000</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">187,500</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">187,503</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">98,379</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">19,989</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">868,371</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Financial Planning and Analysis<SUP>(4)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_______________</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(1)</SUP></FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The value for the stock awards is based
        on the number of shares granted multiplied by the closing share price of our common stock on the date of grant. These are not amounts
        actually paid to or realized by the Named Executive Officer. In accordance with SEC rules, the grant date fair value for stock
        options is calculated based on a Black Scholes valuation of each award, determined under FASB ASC 718 incorporating the following
        assumptions: expected life 6 years; weighted average volatility 46.9%; risk free interest rate 2.7%; and expected dividend yield
        0%. We used historical stock prices as the basis for the volatility assumptions. The risk free interest rate was based on U.S.
        Treasury rates in effect at the time of grant. See Note 11, Stock-Based Compensation, to our audited financial statements for the
        fiscal year ended December 31, 2019, included in our Annual Report on Form 10-K filed with the SEC on March 16, 2020, for a further
        discussion of the relevant valuation assumptions used in calculating grant date fair value.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 48px"><FONT STYLE="font-size: 10pt"><SUP>(2)</SUP></FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For 2019, the Named Executive
Officers received the following: (i) an annual car allowance as follows: $9,600 for Mr. Stolper, $15,000 for Mr. Forthuber, $4,875
for Mr. Hames, and $18,000 for Mr. Patel; (ii) RadNet paid premiums for coverage under RadNet&rsquo;s group health insurance plans
in the following amounts: <FONT STYLE="background-color: white">$13,002 for Dr. Berger, $12,096 for Mr. Stolper, $13,025 for Mr.
Forthuber, $4,646 for Mr. Hames and $12,366 for Mr. Patel; (iii) Messrs. Stolper, Forthuber, Hames and Patel each received a 401(k)
retirement plan match from RadNet in the amount of $2,800; (iv) RadNet paid premiums for life insurance coverage under the COLI
policies</FONT> in the following amounts: $35,023 for Dr. Berger, $680 for Mr. Stolper, $1,520 for Mr. Forthuber, $2,120 for Mr.
Hames, and $390 for Mr. Patel; and (v) <FONT STYLE="background-color: white">RadNet paid premiums for life insurance coverage
under RadNet&rsquo;s group </FONT>life insurance plans in the following amounts: $376 for Dr. Berger, $432 for Mr. Stolper, $1,090
for Mr. Forthuber, $432 for Mr. Hames, and $432 for Mr. Patel.</P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 48px"><FONT STYLE="font-size: 10pt"><SUP>(3)</SUP></FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">$500,000 of the base salary and all of the
        bonus compensation paid to Dr. Berger in each year was paid by an affiliate of BRMG, a consolidated entity.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(4)</SUP></FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Mr. Patel became a Named Executive Officer in 2018.</FONT></TD></TR>
</TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a34"></A>Grants of Plan-Based Awards</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below sets
forth certain information with respect to grants of awards to our Named Executive Officers under the Restated 2006 Plan during
2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 23%; border-bottom: black 1pt solid; text-align: center; font-weight: bold">Name</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 10%; border-bottom: black 1pt solid; text-align: center; font-weight: bold">Grant Date</TD>
    <TD STYLE="width: 1%; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 18%; border-bottom: black 1pt solid; text-align: center; font-weight: bold">All Other Stock Awards: <BR>
Number of Shares<BR>
of Stock or Units (#) <SUP>(1)</SUP></TD>
    <TD STYLE="width: 1%; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 17%; border-bottom: black 1pt solid; text-align: center; font-weight: bold">All Other Option Awards: Number of Securities Underlying Options <SUP>(2)</SUP></TD>
    <TD STYLE="width: 1%; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 15%; border-bottom: black 1pt solid; text-align: center; font-weight: bold">Exercise or Base Price of Option Awards ($/Share)</TD>
    <TD STYLE="width: 1%; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 12%; border-bottom: black 1pt solid; text-align: center; font-weight: bold">Grant Date Fair Value of Stock and Option Awards ($) <SUP>(3)</SUP></TD></TR>
<TR STYLE="background-color: #F2F2F2">
    <TD STYLE="vertical-align: bottom; text-align: left">Stephen M. Forthuber</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">01/07/19</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">25,158</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">274,977</TD></TR>
<TR STYLE="background-color: rgb(238,238,238)">
    <TD STYLE="vertical-align: bottom; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">01/07/19</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">25,158</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">10.93</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">131,842</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom; text-align: left">Norman R. Hames</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">01/07/19</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">25,158</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">274,977</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">01/07/19</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">25,158</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">10.93</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">131,842</TD></TR>
<TR STYLE="background-color: rgb(238,238,238)">
    <TD STYLE="vertical-align: bottom; text-align: left">Mark D. Stolper</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">01/07/19</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">21,729</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">237,498</TD></TR>
<TR STYLE="background-color: rgb(238,238,238)">
    <TD STYLE="vertical-align: bottom; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">01/07/19</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">21,729</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">10.93</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">113,877</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom; text-align: left">Mital Patel</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">01/07/19</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">17,154</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">187,493</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">01/07/19</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">17,154</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">10.93</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">89,897</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_______________</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 3pt; width: 48px; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(1)</SUP></FONT></TD>
    <TD STYLE="padding-top: 3pt; text-align: justify"><FONT STYLE="font-size: 10pt">Each restricted stock/RSU award vests in equal annual increments on January 7 of 2019, 2020 and 2021, subject to the officer&rsquo;s continued service. Please see footnote (2) to the table under Outstanding Equity Awards at Fiscal Year End, below, for a description of conditions which cause acceleration of vesting for outstanding stock awards.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(2)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Each stock option award vests in equal annual increments on January 7 of 2020, 2021 and 2022, subject to the officer&rsquo;s continued service. Please see footnote (1) to the table under Outstanding Equity Awards at Fiscal Year End, below, for a description of conditions which cause acceleration of vesting for outstanding stock option awards. All stock options have a ten year maximum term.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(3)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">For discussion regarding the valuation model and assumptions used to calculate the grant date fair value of these stock and option awards, see footnote (1) to the Summary Compensation Table.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a35"></A>Outstanding Equity Awards at Fiscal
Year End</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below summarizes
outstanding equity awards held by our Named Executive Officers at December 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="9" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">OPTION AWARDS</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">STOCK AWARDS</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1pt solid">Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of Securities Underlying Unexercised Options (#)(1) Exercisable</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of Securities Underlying Unexercised Options <BR> (#)(1) Unexercisable</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Option Exercise Price ($)</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Option Expiration Date</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of Shares or Units of Stock That Have Not Vested (#)(2)</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Market Value of Shares or Units of Stock That Have&nbsp;Not Vested ($)(3)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 28%; text-align: justify">Stephen M. Forthuber</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: right">25,893</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: right">525,628</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;January 4, 2016 Grant</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">26,086</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">13,041</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6.07</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1/4/2026</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;January 6, 2017 Grant</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">12,566</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">25,132</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6.30</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1/6/2027</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;January 2, 2018 Grant</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">27,363</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">10.05</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1/2/2028</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;January 7, 2019 Grant</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">25,158</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">10.93</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1/7/2029</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Norman R. Hames</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">25,893</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">525,628</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;January 4, 2016 Grant</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">26,086</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">13,041</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6.07</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1/4/2026</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;January 6, 2017 Grant</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">12,566</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">25,132</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6.30</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1/6/2027</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;January 2, 2018 Grant</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">27,363</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">10.05</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1/2/2028</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;January 7, 2019 Grant</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">25,158</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">10.93</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1/7/2029</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: justify">Mark D. Stolper <FONT STYLE="font-size: 10pt"><B><SUP>(4)</SUP></B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">22,363</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">453,969</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;January 4, 2016 Grant</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">23,802</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">11,901</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6.07</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1/4/2026</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;January 6, 2017 Grant</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">11,466</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">22,933</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6.30</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1/6/2027</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;January 2, 2018 Grant</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">21,564</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">10.05</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1/2/2028</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;January 7, 2019 Grant</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">19,828</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">10.93</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1/7/2029</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Mital Patel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">17,655</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">358,397</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;January 6, 2017 Grant</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">9,920</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">19,842</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6.30</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1/6/2027</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;January 2, 2018 Grant</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">18,657</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">10.05</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1/2/2028</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;January 7, 2019 Grant</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">17,154</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">10.93</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1/7/2029</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; border-bottom-width: 0in; border-bottom-color: Black">_______________</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 3pt; width: 5%; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(1)</SUP></FONT></TD>
    <TD STYLE="padding-top: 3pt; width: 95%; text-align: justify"><FONT STYLE="font-size: 10pt">Relates to stock options issued under the Restated 2006 Plan. All stock options have a ten-year term from the date of grant.&nbsp;&nbsp;For stock options granted between 2016 and 2018, one-third of the stock options vest on the second anniversary of the date of grant and the remaining portion of the options vest in equal increments on the third and fourth anniversaries of the date of grant. For stock options granted in 2019, one-third of the stock options incrementally vest on each of the first three anniversaries of the date of grant. Additionally, vesting accelerates on outstanding awards (i) upon termination of the officer&rsquo;s service due to his death or Disability or (ii) on a &ldquo;dual trigger&rdquo; basis if, in anticipation of or during the 24 months following a change in control of RadNet, the employment of the Named Executive Officer is terminated either by RadNet without Cause or by the Named Executive Officer for Good Reason. However, for Messrs. Forthuber and Stolper, their respective employment agreements provide that vesting accelerates such that all options, warrants and any other deferred equity compensation granted by RadNet to Messrs. Forthuber and Stolper which are unvested at the date of a change in control will immediately vest upon such change in control that occurs during their employment. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(2)</SUP></FONT></TD>
    <TD STYLE="text-align: justify; width: 95%">Relates to restricted stock/RSUs granted under the Restated 2006 Plan. One-third of the stock awards are fully-vested as of the date of grant and the remaining portion of the stock awards vest in equal increments on the first and second anniversaries of the date of grant. Vesting accelerates on outstanding awards (i) upon termination of the officer&rsquo;s service due to his death or Disability or (ii) on a &ldquo;dual trigger&rdquo; basis if, in anticipation of or during the 24 months following a change in control of RadNet, the employment of the Named Executive Officer is terminated either by RadNet without Cause or by the Named Executive Officer for Good Reason. However, for Messrs. Forthuber and Stolper, their respective employment agreements provide that vesting accelerates such that all options, warrants and any other deferred equity compensation then granted to Messrs. Forthuber and Stolper which are unvested at the date of a change in control will immediately vest upon such change in control that occurs during their employment. </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 95%">The number of shares of restricted stock/RSUs held by each of the Named Executive Officers, which were issued on January 2, 2018 and on January 7, 2019, respectively, will vest, subject to the officer&rsquo;s continued service, according to the below schedule: &nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="RIGHT" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="5" STYLE="border-bottom: Black 1pt solid; text-align: center">Number of Shares Incrementally Vesting</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">Name</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">January 2, 2020</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">January 7, 2020</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">January 7, 2021</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 38%; text-align: left">Mark D. Stolper</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 17%; text-align: center">7,877</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 17%; text-align: center">7,243</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 17%; text-align: center">7,243</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Stephen M. Forthuber</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">9,121</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">8,386</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">8,386</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Norman R. Hames</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">9,121</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">8,386</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">8,386</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Mital Patel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">6,219</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">5,718</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">5,718</TD></TR>
</TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(3)</SUP></FONT></TD>
    <TD STYLE="text-align: justify; width: 95%"><FONT STYLE="font-size: 10pt">The aggregate market value is determined by multiplying the number of shares that have not vested by $20.30 per share, the closing price of our common stock as of December 31, 2019. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(4)</SUP></FONT></TD>
    <TD STYLE="text-align: justify; width: 95%"><FONT STYLE="font-size: 10pt">Amounts of stock options and RSUs listed for Mr. Stolper are
    net of the portion transferred to his former spouse.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a36"></A>Option Exercises and Stock Vested
During 2019</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
sets forth information for the Named Executive Officers regarding the value realized during 2019 pursuant to the vesting of restricted
stock, or RSUs in the case of Mr. Stolper. No stock options were exercised by any Named Executive Officer during 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">STOCK AWARDS</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of Shares Acquired on Vesting (#)</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Value Realized on Vesting ($)<SUP>(1)</SUP></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 58%; text-align: justify">Mark D. Stolper</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 20%; text-align: right">25,897</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 20%; text-align: right">275,204</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Stephen M. Forthuber</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">30,073</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">319,510</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: justify">Norman R. Hames</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">30,073</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">319,510</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Mital Patel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">21,858</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">232,116</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border-bottom-width: 0in; border-bottom-color: Black">_______________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 48px; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(1)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The value realized on vesting is determined by multiplying the number of shares that vested by the per share closing price of our common stock on the vesting date.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a37"></A>Pension Benefits, Nonqualified Defined
Contribution and Other Deferred Compensation Plans</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We do not have any
tax-qualified defined benefit plans or supplemental executive retirement plans that provide for payments or other benefits to our
Named Executive Officers in connection with their retirement. However, we do have a Deferred Compensation Plan that was adopted
by the Board of Directors in 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The employment arrangements
of some of our Named Executive Officers include a required payment of deferred compensation upon termination of employment in certain
situations. The following table shows the contributions, earnings and current required payments of deferred compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Executive Contributions in Last Fiscal Year ($)<SUP>(1)</SUP></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Registrant Contributions in Last Fiscal Year ($)</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Aggregate Earnings in Last Fiscal Year ($)<SUP>(2)</SUP></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Aggregate Withdrawals/ Distributions ($)</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Aggregate Balance at Last Fiscal Year End ($)<FONT STYLE="font-size: 10pt"><SUP>(5)</SUP></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 27%; text-align: left">Howard G. Berger, M.D.</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 13%; text-align: center">&ndash;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 13%; text-align: center">&ndash;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 13%; text-align: center">&ndash;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 13%; text-align: center">&ndash;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 13%; text-align: center">2,500,000</TD>
    <TD STYLE="width: 3%">(3)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Norman R. Hames</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&ndash;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&ndash;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&ndash;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&ndash;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1,050,000</TD>
    <TD>(4)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: justify">Mark D. Stolper</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">216,720</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&ndash;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">752,694</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&ndash;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1,538,558</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border-bottom-width: 0in; border-bottom-color: Black">_______________</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(1)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><P STYLE="margin-top: 0; margin-bottom: 0">In 2019, Mr. Stolper elected to defer his stock
grant (net of shares transferred to his former spouse), resulting in his receipt of 19,828 RSUs. On the date of grant of his RSUs,
the share price was $10.93 and on December 31, 2019 the share price was $20.30. For Mr. Stolper, $237,500 has been reported as
compensation in the Summary Compensation Table for 2019, which represents the value of his stock grant prior to the transfer of
shares to his former spouse. The following table shows the number of RSUs held by Mr. Stolper at the beginning of 2019 and the
total held at the end of&nbsp; 2019. </P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="RIGHT" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">Restricted Stock Units at December 31, 2018</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">Restricted Stock Units Deferred
during 2019</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">Total RSUs held at December 31, 2019</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 38%; text-align: left">Mark D. Stolper</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 17%; text-align: center">55,963</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 17%; text-align: center"> 19,828</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 17%; text-align: center">75,791 </TD></TR>
</TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 48px"><FONT STYLE="font-size: 10pt"><SUP>(2)</SUP></FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Amount represents stock price appreciation
        in 2019 on all RSUs. No portion of the earnings has been reported as compensation in the Summary Compensation Table for 2019.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(3)</SUP></FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Management Consulting Agreement
        dated as of January 1, 1994, as amended, Dr. Berger is entitled to receive, upon termination of his employment without cause by
        the Company, an amount equal to five times his 2010 base salary paid by BRMG. Upon termination of his employment by the Company
        for cause, Dr. Berger is entitled to an amount equal to his 2010 base salary paid by BRMG. If Dr. Berger voluntarily resigns his
        employment, then on cessation of employment Dr. Berger will be entitled to receive compensation in an amount equal to five times
        his 2010 base salary paid by BRMG. Dr. Berger&rsquo;s 2010 base salary as paid by BRMG was $500,000. Such post-employment payment
        is subject to post-termination covenants intended to protect RadNet&rsquo;s business.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(4)</SUP></FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Employment Agreement dated
        as of May 1, 2001, as amended, Mr. Hames is entitled to receive, upon termination of employment without cause by the Company, an
        amount equal to three times his 2010 base salary. Upon termination of his employment by the Company for cause, Mr. Hames is entitled
        to an amount equal to his 2010 base salary. If Mr. Hames voluntarily resigns his employment, then on cessation of employment Mr.
        Hames will be entitled to receive compensation in an amount equal to three times his 2010 base salary. Mr. Hames&rsquo; 2010 base
        salary was $350,000. Such post-employment payment is subject to post-termination covenants intended to protect RadNet&rsquo;s business.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 48px"><FONT STYLE="font-size: 10pt"><SUP>(5)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Of the $1,538,558 reported for Mr. Stolper, $237,500 is reported in the Summary Compensation Table for 2019. $474,992, in the aggregate, was reported for Mr. Stolper in the Summary Compensation Table for prior years. None of the $2,500,000 reported for Dr. Berger or the $1,050,000 reported for Mr. Hames is reported in the Summary Compensation Table for 2019 or was reported in the Summary Compensation Table for any prior years.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a38"></A>Employment Agreements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Dr. Berger. </I>Dr.
Berger has a Management Consulting Agreement with BRMG dated January 1, 1994 and an employment agreement with us dated as of June
12, 1992. The terms of the employment agreement provide for a base salary which has been subsequently amended from time to time
and, effective January 1, 2020, is $1,200,000. Under the terms of the Management Consulting Agreement, in the event of termination
or voluntary resignation &ldquo;without cause,&rdquo; Dr. Berger is entitled to receive a severance payment in an amount equal
to five times his 2010 BRMG annual compensation, or $2,500,000 (which represents five-sixths of his 2019 total cash compensation),
which such amount is also payable in certain other circumstances as set forth under &ldquo;Nonqualified Deferred Compensation&rdquo;
above. Separately, in the event of termination &ldquo;for cause&rdquo; by BRMG, Dr. Berger is entitled to receive compensation
in an amount equal to his 2010 annual base compensation from an affiliate of BRMG, or $500,000. BRMG may terminate Dr. Berger&rsquo;s
consulting services &ldquo;for cause&rdquo; if (1) there is a material breach by Dr. Berger of the agreement which persists for
more than thirty (30) days after notice of such breach has been provided, (2) Dr. Berger willfully breaches or habitually neglects
his duties, (3) Dr. Berger commits any acts of a criminal nature, fraud, dishonest misrepresentations or any acts of moral turpitude,
(4) Dr. Berger&rsquo;s professional license is suspended, revoked or terminated or (5) Dr. Berger is convicted of a felony or of
fraud involving payments or charges for professional medical services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Mr. Forthuber</I>.
We entered into an employment agreement with Mr. Forthuber on January 1, 2009 and a retention agreement on November 15, 2006, each
of which have been subsequently amended. The employment agreement provides for a base salary of $550,000, and has since been amended
to $600,000, effective January 1, 2020. Under the employment agreement, all options, warrants and any other deferred equity compensation
then granted to Mr. Forthuber which are unvested at the date of a change in control in RadNet will vest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we terminate Mr.
Forthuber&rsquo;s employment for any reason other than for &ldquo;disability&rdquo; or &ldquo;cause,&rdquo; or if Mr. Forthuber
resigns for &ldquo;good reason,&rdquo; Mr. Forthuber will be entitled to receive a lump sum severance payment in an amount equal
to twice his then annual salary, which would have been $1,100,000 if he was hypothetically terminated on December 31, 2019, subject
to Mr. Forthuber complying with certain post-termination covenants for twelve months from the effective date of termination intended
to protect RadNet&rsquo;s business. In addition, all outstanding stock options, warrants restricted stock and any other deferred
equity compensation granted by RadNet to Mr. Forthuber which are then unvested shall immediately vest at such termination of employment.
Under the employment agreement, &ldquo;disability&rdquo; means that Mr. Forthuber is unable to perform the essential functions
of his job, even with reasonable accommodation, on account of a mental or physical condition for a period of at least 120 days
during any twelve consecutive month period. We may terminate Mr. Forthuber&rsquo;s employment for &ldquo;cause&rdquo; (1) if Mr.
Forthuber was convicted (or pleads guilty or nolo contendere) of a felony or a misdemeanor involving fraud or dishonesty in connection
with the performance of his duties under the retention agreement or moral turpitude, (2) based on the willful and continued failure
of Mr. Forthuber for a total of 10 days within any fiscal year to substantially perform his or (3) Mr. Forthuber has willfully
engaged in misconduct which has, or can reasonably be expected to have, a direct and material adverse monetary effect on RadNet.
Under the employment agreement, &ldquo;good reason&rdquo; means (1) a material default by the Company in the performance of any
of its obligations hereunder, or (2) an Adverse Change in Duties (as defined in the employment agreement), which default or Adverse
Change in Duties remains unremedied by the Company for a period of ten days following its receipt of written notice thereof from
Employee (which notice must reasonably describe the facts claimed by Employee to constitute the default or Adverse Change in Duties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Mr. Hames. </I>We
entered into an employment agreement with Mr. Hames on May 1, 2001, which was subsequently amended, that provides for a term that
renews automatically for successive one year terms unless otherwise terminated by either party. The employment agreement, as amended,
provides for a base salary of $550,000, and has since been amended to $600,000, effective as of January 1, 2020. Unless we terminate
Mr. Hames&rsquo; employment &ldquo;for cause&rdquo; or if Mr. Hames voluntarily resigns &ldquo;without cause,&rdquo; on cessation
of employment Mr. Hames will be entitled to receive a severance payment in an amount equal to three times his 2010 base salary,
or $1,050,000, subject to post-termination covenants intended to protect RadNet&rsquo;s business. We may terminate Mr. Hames&rsquo;
employment &ldquo;for cause&rdquo; if (1) there is a material breach of the agreement which persists for more than thirty (30)
days after notice of such breach has been provided, (2) Mr. Hames willfully breaches or habitually neglects his duties or (3) Mr.
Hames commits any acts of a criminal nature, fraud, dishonest misrepresentations or any acts of moral turpitude. If we terminate
Mr. Hames&rsquo; employment &ldquo;for cause,&rdquo; the employment agreement provides that Mr. Hames will be entitled to receive
compensation in an amount equal to his 2010 base salary, or $350,000.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Mr. Stolper. </I>We
entered into an employment agreement with Mr. Stolper effective as of January 1, 2009, as amended on November 16, 2015, under which
he serves as our Executive Vice President and Chief Financial Officer until the agreement is terminated by either party. The employment
agreement, as amended provides for a base salary of $475,000, and has since been amended to $525,000, effective January 1, 2020.
The employment agreement also provides that he is eligible to participate in all of our bonus or incentive compensation plans generally
available to our corporate officers. Under the employment agreement, all of Mr. Stolper&rsquo;s unvested outstanding options, warrants
and any other deferred equity compensation will vest on the date of a change in control of RadNet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we terminate Mr.
Stolper&rsquo;s employment &ldquo;without cause&rdquo; or he voluntarily terminates his employment for &ldquo;good reason,&rdquo;
Mr. Stolper is entitled to receive a lump sum severance payment in an amount equal to two times his then annual base salary, which
would have been $950,000 if he was hypothetically terminated on December 31, 2019, subject to Mr. Stolper complying with certain
post-termination covenants for twelve months from the effective date of termination intended to protect RadNet&rsquo;s business.
In addition, all options, warrants or other deferred equity compensation then granted to Mr. Stolper which is unvested at the time
of such termination shall immediately vest. We may terminate Mr. Stolper&rsquo;s employment &ldquo;for cause&rdquo; (1) if Mr.
Stolper is convicted (or pleads guilty or <I>nolo contendere</I>) of a felony or a misdemeanor involving fraud or dishonesty in
connection with the performance of his duties under the employment agreement or moral turpitude, (2) based on the willful and continued
failure of Mr. Stolper to perform his duties for a period of 10 days within one fiscal year or (3) based on Mr. Stolper&rsquo;s
willingness to engage in misconduct which has, or can reasonably be expected to have, a direct and material adverse monetary effect
on RadNet. Mr. Stolper may terminate his employment for &ldquo;good reason&rdquo; (1) if RadNet materially defaults on its obligations
under the employment agreement or (2) if without his consent, his title, duties or job functions are materially diminished, he
is assigned duties or responsibilities materially inconsistent with his current position, or he is relocated, and such changes
remain unremedied for a period of ten days following notice from Mr. Stolper.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a39"></A>Potential Payments Upon Termination
or Change in Control</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Payments Made Upon Termination and Retirement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Regardless of the manner
in which the employment of a Named Executive Officer is terminated, he is entitled to receive amounts earned during his term of
employment. Such amounts include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">non-equity incentive compensation earned, to the extent vested;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">equity awarded pursuant to our Restated 2006 Plan, to the extent vested; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">unused vacation pay.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Payments Made Upon Death or Disability</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of the
death or disability of a Named Executive Officer, no additional benefits other than those listed under the heading &ldquo;Payments
Made Upon Termination and Retirement&rdquo; above, will be paid to our Named Executive Officers except for life insurance proceeds
payable upon death and any then-unvested portion of an existing stock option/RSU/restricted stock award shall immediately vest
upon such death or termination due to Disability (as defined in the Restated 2006 Plan). In connection with the death of a Named
Executive Officer while still in service with RadNet, (1) <FONT STYLE="background-color: white">the COLI policy death benefit proceeds
payable would be $5 million for Dr. Berger and $1 million for each of the other Named Executive Officers</FONT> and (2) <FONT STYLE="background-color: white">the
group </FONT>life insurance plans <FONT STYLE="background-color: white">death benefit proceeds payable would </FONT>be $20,000
for Dr. Berger and $100,000 for each of <FONT STYLE="background-color: white">the other Named Executive Officers</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white"></FONT>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Severance Arrangements </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have severance obligations
to our Named Executive Officers under each employment agreement discussed above under the heading &ldquo;Employment Agreements.&rdquo;
The severance payments described above are payable within fifteen business days of the effective date of such termination; provided,
that, if Named Executive Officer is deemed a &ldquo;specified employee&rdquo; and the payments are subject to Section 409A of the
Code, then the payment may be required to be deferred until the first day of the seventh month following the effective date of
such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Change-in-Control Arrangements</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Restated
2006 Plan, the Board of Directors of RadNet, a committee thereof, or the board of directors of any surviving entity or acquiring
entity, may accelerate the vesting of all or any part of outstanding stock options and terminate any restrictions on all or any
part of the restricted stock awards in connection with a &ldquo;change-in-control.&rdquo; A &ldquo;change-in-control&rdquo; under
the Restated 2006 Plan means: (1) a merger or consolidation in which RadNet is not the surviving entity (or survives only as a
subsidiary of another entity whose stockholder did not own all or substantially all of our common stock immediately before such
transaction); (2) a sale of all or substantially all of our assets to another person or entity (other than a wholly-owned subsidiary);
(3) an acquisition of beneficial ownership of a controlling interest in the outstanding shares of our common stock by any person
or entity (including a &ldquo;group&rdquo;) as defined under Section 13(d)(3) of the Exchange Act); (4) the dissolution or liquidation
of RadNet; (5) a contested director election that results in the persons who were directors before such election or their nominees
ceasing to constitute a majority of the board or (6) any other event that may be specified in the specific awards granted by the
Board of Directors or a committee thereof pursuant to the Restated 2006 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Generally, awards to
our Named Executive Officers under our 2006 Restated Plan will accelerate if the Named Executive Officer is terminated without
Cause or resigns for Good Reason within 24 months of a change in control. Under the employment agreements for Messrs. Forthuber
and Stolper, all options, restricted stock, warrants and any other deferred equity compensation which is unvested at the time of
a change in control that occurs during their employment shall immediately vest. Hypothetically assuming a change-in-control occurred
on December 31, 2019, the intrinsic value of such newly vested options, restricted stock and other deferred equity compensation
payable to Messrs. Forthuber and Stolper would have been approximately $1,579,251 and $1,437,209, respectively, based on our December
31, 2019 closing per share price of $20.30.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a40"></A>EQUITY COMPENSATION PLAN INFORMATION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have one equity
compensation plan, our Restated 2006 Plan. The Restated 2006 Plan provides for the grant of stock options (incentive and non-qualified),
stock awards (including RSUs), stock appreciation rights and cash awards. We reserved an aggregate 14,000,000 shares of common
stock for issuance under our Restated 2006 Plan, subject to adjustment for stock dividends, reorganizations, or other changes in
our capital structure. Shares underlying any portion of an award that is cancelled, terminates, expires, or lapses for any reason
are generally returned to the available pool under the Restated 2006 Plan. Notwithstanding the foregoing, the aggregate number
of shares of common stock that may be issued under the Restated 2006 Plan upon the exercise of incentive stock options shall not
be increased for restricted shares that are forfeited or repurchased. Shares attributable to (a) shares of common stock upon the
exercise of incentive stock options that are subsequently forfeited or repurchased, or (b) awards transferred under any award transfer
program, shall not again be available for grant under the Restated 2006 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
sets forth the number of shares of common stock subject to outstanding options, RSUs, warrants and other convertible into share
rights, the weighted-average exercise price of outstanding options, and the number of shares remaining available for future award
grants as of December 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Plan Category</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>(A) <BR> Number of Shares to Be Issued Upon Exercise of Outstanding Options, Warrants and Rights (#) <SUP>(1)</SUP></B></FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">(B) <BR> Weighted Average Exercise Price of Outstanding Options, Warrants and Rights ($)</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">(C) <BR> Number of Shares Remaining Available For Future Issuance Under Equity Incentive Plans (Excluding Shares Reflected in Column (A))</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 58%; text-align: justify; padding-bottom: 1pt">Equity incentive plans approved by stockholders</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 13%; text-align: right">773,841</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 13%; text-align: right">8.21</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 13%; text-align: right">2,172,159</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1pt">Equity incentive plans not approved by stockholders</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">TOTAL</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right">773,841</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: center">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">_______________</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: justify"><FONT STYLE="font-size: 10pt"><SUP>(1)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Includes 294,890 shares subject to outstanding RSUs under the Deferred Compensation Plan. The weighted average exercise price in column (B) does not take these RSUs into account.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a41"></A>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL
OWNERS AND MANAGEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
presents information concerning the beneficial ownership of the shares of our common stock as of March 31, 2020, by:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">each person we know to be the beneficial owner of 5% or more of our outstanding shares of common stock;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">each of our Named Executive Officers; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">each of our directors; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">all of our current executive officers and directors as a group.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise noted
below, the address of each beneficial owner listed in the table is c/o RadNet, Inc., 1510 Cotner Ave., Los Angeles, CA 90025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as indicated
by the footnotes below, we believe, based on the information furnished to us, that the persons and entities named in the table
below have sole voting and investment power with respect to all shares of common stock that they beneficially own, subject to applicable
community property laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Applicable percentage
ownership is based on 50,694,375 shares of common stock outstanding on March 31, 2020. In accordance with Securities and Exchange
Commission (the &ldquo;SEC&rdquo;) rules, when computing the number of shares of common stock beneficially owned and the percentage
ownership of a person, we include shares of common stock subject to options held by that person that are exercisable or will become
exercisable within 60 days of March 31, 2020, but we do not include those shares of common stock underlying options when computing
the percentage ownership of any other person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Name of Beneficial Owner</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Shares Beneficially Owned</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Percent of Shares Beneficially <BR>
Owned</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="width: 57%; text-align: justify; font-weight: bold">5% or Greater Stockholders</TD>
    <TD STYLE="width: 4%; text-align: justify; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 17%; text-align: justify; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: justify; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: justify; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 17%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Sandy Nyholm Kaminsky, trustee of the HFB Heirs&rsquo; Trust II (formerly HFB Heirs&rsquo; Trust)</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">5,376,253</TD>
    <TD STYLE="text-align: justify"><SUP>(1)</SUP>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;10.61%</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="text-align: justify">The Vanguard Group</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">2,560,767</TD>
    <TD STYLE="text-align: justify"><SUP>(2)</SUP></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">5.05%</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Alan Weber</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">2,932,200</TD>
    <TD STYLE="text-align: justify"><SUP>(3)</SUP></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">5.78%</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="text-align: justify">BlackRock, Inc.</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">6,553,079</TD>
    <TD STYLE="text-align: justify"><SUP>(4)</SUP></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">12.93%</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">FMR LLC</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">3,329,030</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><SUP>(5)</SUP></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">6.57%</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="text-align: justify"><B>Directors and Named Executive Officers</B></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Howard G. Berger, M.D.</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">0</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><SUP>(6)</SUP></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">0</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="text-align: justify">Marvin S. Cadwell</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">285,475</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><SUP>(7)</SUP></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">*</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">John V. Crues, III, M.D.</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">429,415</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><SUP>(8)</SUP></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">*</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="text-align: justify">Stephen M. Forthuber</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">554,672</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><SUP>(9) </SUP></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">1.09%</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify">Norman R. Hames</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">624,387</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><SUP>(10)</SUP></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">1.23%</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="text-align: justify">Laura P. Jacobs</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">0</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><SUP>(11)</SUP></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">0</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify">Lawrence L. Levitt</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">167,817</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><SUP>(12)</SUP></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">*</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="text-align: justify">Mital Patel</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">162,192</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><SUP>(13)</SUP></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">*</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify">Michael L. Sherman, M.D.</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">259,083</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><SUP>(14)</SUP></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">*</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="text-align: justify">Mark D. Stolper</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">163,909</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><SUP>(15)</SUP></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">*</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify">David L. Swartz</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">180,377</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><SUP>(16)</SUP></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">*</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="text-align: justify">Ruth V. Wilson</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">22,000</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><SUP>(17)</SUP></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">*</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify"><B>All directors and executive officers as a group (12 persons)</B></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right"><B>2,949,902</B></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">5.77%</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_______________</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 48px; text-align: left"><FONT STYLE="font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Represents less than 1%.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(1)</SUP></FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">According to the Schedule 13G/A filed with
        the SEC on October 6, 2017, Sandy Nyholm Kaminsky, as trustee of the HFB Heirs&rsquo; Trust II, maintains sole voting power over
        an aggregate of 5,376,253 shares of our common stock. The address set forth in the Schedule 13G filing is 400 S. Emerson Street,
        Denver, Colorado 80209.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(2)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">According to the Schedule 13G filed with the SEC on February
    11, 2020, The Vanguard Group maintains sole dispositive power over 2,474,836 shares of our common stock and shared
    dispositive power over 85,931 shares of our common stock. The address set forth in the 13G filing is 100 Vanguard Blvd.,
    Malvern, PA 19355.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(3)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">According to the Schedule 13D/A filed with the SEC on June 5, 2015, Mr. Weber maintains sole voting power over an aggregate of 618,106 shares of our common stock and shared voting power over an aggregate of 2,314,094 shares of our common stock owned by JB Capital Partners LP. Mr. Weber is the general partner of JB Capital Partners LP. Mr. Weber and JB Capital Partners LP disclaim beneficial ownership of all of such shares except to the extent of their pecuniary interest therein. The address set forth in the Schedule 13D/A filing is 5 Evan Place, Armonk, New York 10504.</FONT></P>
                                    <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(4)</SUP></FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">According to the Schedule 13G/A filed with
        the SEC on February 4, 2020, BlackRock, Inc. maintains sole voting power over 6,461,068 shares of our common stock and sole dispositive
        power over 6,553,079 shares of our common stock. The address set forth in the Schedule 13G/A filing is 55 East 52<SUP>nd</SUP>
        Street, New York, New York 10055.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><SUP>(5)</SUP></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">According to the Schedule 13G filed with the SEC on February 7, 2020, FMR LLC maintains sole voting power over 2,607,230 shares of our common stock and sole dispositive power over 3,329,030 shares of our common stock. The address set forth in the 13G filing is 245 Summer Street, Boston, Massachusetts 02210.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(6)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">On June 29, 2015, HFB Enterprises, LLC, of which Dr. Berger was a co-manager, distributed 5,133,114 shares of RadNet&rsquo;s common stock to HFB Heirs&rsquo; Trust II (formerly HFB Heirs&rsquo; Trust), an irrevocable trust for Dr. Berger&rsquo;s children and the sole member of HFB Enterprises, LLC. Dr. Berger does not have any control over HFB Heirs&rsquo; Trust II. As a result of the transaction, Dr. Berger does not beneficially own any shares of RadNet. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(7)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Beneficial ownership includes 9,363 shares of unvested time-based restricted stock and no shares subject to options exercisable within 60 days of March 31, 2020.&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(8)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Beneficial ownership includes 12,364 shares of unvested
    time-based restricted stock and no shares subject to options exercisable within 60 days of March 31, 2020. Beneficial
    ownership does not include 28,334 shares of vested restricted stock units.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(9)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Beneficial ownership includes 17,360 shares of unvested time-based restricted stock and 81,768 shares subject to options exercisable within 60 days of March 31, 2020.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(10)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Beneficial ownership includes 17,360 shares of unvested time-based restricted stock and 81,768 shares subject to options exercisable within 60 days of March 31, 2020. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(11)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Laura P. Jacobs is a director nominee and does not beneficially own any shares of RadNet.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(12)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Beneficial ownership includes 9,363 shares of unvested time-based restricted stock and no shares subject to options exercisable within 60 days of March 31, 2020.&nbsp;&nbsp;Beneficial ownership does not include 39,382 shares of vested restricted stock units.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(13)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Beneficial ownership includes 12,652 shares of unvested restricted stock and 31,778 shares subject to options exercisable within 60 days of March 31, 2020.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(14)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Beneficial ownership includes 9,363 shares of unvested time-based restricted stock and no shares subject to options exercisable within 60 days of March 31, 2020.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(15)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Beneficial ownership includes 72,433 shares subject to options exercisable within 60 days of March 31, 2020.&nbsp;&nbsp;Beneficial ownership does not include 72,717 shares of vested restricted stock units.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(16)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Beneficial ownership includes 9,363 shares of unvested
    time-based restricted stock and no shares subject to options exercisable within 60 days of March 31, 2020. Beneficial
    ownership does not include 39,382 shares of vested restricted stock units.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>(17)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Beneficial ownership includes 10,666 shares of unvested restricted stock and no shares subject to options exercisable within 60 days of March 31, 2020.&nbsp;&nbsp;Beneficial ownership does not include 32,000 shares of vested restricted stock units.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a42"></A>DELINQUENT SECTION 16(a) REPORTS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 20pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><B></B>Section 16(a) of the Exchange Act requires our directors, executive officers and beneficial owners of more than 10% of our common stock to file reports of ownership and changes in ownership with the SEC. Based solely on copies of these reports provided to us and written representations that no other reports were required, we believe that these persons timely met all of the applicable Section 16(a) filing requirements during the fiscal year ended December 31, 2019, with the exception of the following, all of which reflect late filings on Form 4 unless otherwise set forth below: (i) Marvin Cadwell had one late report which covered one transaction, (ii) John Crues had two late reports which covered two transactions, (iii) Stephen Forthuber had one late report which covered one transaction, (iv) Norman Hames had two late reports which covered four transactions, (v) Lawrence Levitt had one late report which covered one transaction (vi) Michael Murdock had one late report which covered one transaction, (vii) Mital Patel had one late report which covered two transactions, (viii) Michael Sherman had one late report which covered on transaction, (ix) Mark Stolper had one late report which covered two transactions, (x) David Swartz had three late reports which covered twelve transactions and (xi) Ruth Wilson had one late report covering no transactions, on Form 3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 20pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 20pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 20pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 20pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 20pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 20pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 20pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 20pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 20pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 20pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 20pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 20pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 20pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 20pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 20pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a43"></A>REPORT OF THE AUDIT COMMITTEE OF THE
BOARD OF DIRECTORS*</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee
of the Board of Directors is comprised entirely of independent directors who meet the independence requirements of NASDAQ and the
SEC. The Audit Committee operates pursuant to a charter that is available on our website at <I>www.radnet.com</I> under Investor
Relations &ndash; Corporate Governance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee
oversees our financial reporting process on behalf of the Board of Directors. Management is responsible for the preparation, presentation
and integrity of the financial statements, including establishing accounting and financial reporting principles and designing systems
of internal control over financial reporting. Our independent registered public accounting firm, Ernst &amp; Young LLP (&ldquo;Ernst
&amp; Young&rdquo;), is responsible for expressing an opinion as to the conformity of our consolidated financial statements with
generally accepted accounting principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee
has reviewed and discussed with management and Ernst &amp; Young the audited consolidated financial statements in our annual report
on Form 10-K for the year ended December 31, 2019. The Audit Committee has also discussed with Ernst &amp; Young matters required
to be discussed by the Public Company Accounting Oversight Board and the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee
has received the written disclosures and the letter from Ernst &amp; Young required by applicable requirements of the Public Company
Accounting Oversight Board regarding Ernst &amp; Young&rsquo;s communications with the Audit Committee concerning independence,
and has discussed with Ernst &amp; Young its independence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on the reviews
and discussions referred to above, the Audit Committee recommended to the Board of Directors that the audited consolidated financial
statements discussed above be included in RadNet&rsquo;s annual report on Form 10-K for the year ended December 31, 2019 for filing
with the SEC. The Audit Committee has also reappointed Ernst &amp; Young to serve as independent auditors for the fiscal year ending
December 31, 2020, and requested that this appointment be submitted to our stockholders for ratification at their Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Submitted by the Audit
Committee:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 57%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 43%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">David L. Swartz, Chair</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Marvin S. Cadwell</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lawrence L. Levitt</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_______________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">* The material in this report is not &ldquo;soliciting
material,&rdquo; is not deemed filed with the SEC and is not to be incorporated by reference into any of our filings under the
Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), or the Exchange Act whether made before or after the date
of this Proxy Statement and irrespective of any general incorporation language therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a44"></A>PROPOSALS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROPOSAL NO. 1<BR>
ELECTION OF DIRECTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on the recommendation
of our Nominating and Governance Committee, our Board of Directors has nominated Ms. Jacobs and directors Berger, Cadwell, Crues,
Levitt, Swartz and Wilson to be elected to serve on our Board until the next annual meeting of stockholders and until their successors
are duly elected and qualified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each of the nominees
except Ms. Jacobs is a current director and all have consented to serving as a nominee, being named in this Proxy Statement, and
serving on the Board if elected. Each director elected at the Annual Meeting will be elected to serve a one-year term. If any nominee
becomes unavailable or unable to serve before the Annual Meeting, the Board of Directors may determine to leave the position vacant,
reduce the number of authorized directors or designate a substitute nominee. If a substitute nominee is named, then the persons
named as proxies will have full discretion and authority to vote or refrain from voting for such substitute nominee in their discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are no family
relationships between any nominees and executive officers of RadNet, and there are no arrangements or understandings between any
nominee and any other person pursuant to which such nominee was or is selected as a director or nominee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Voting on the election
of directors is considered a non-routine matter, and the persons named in the accompanying proxy will not have the authority to
vote on this proposal unless instructed to do so by the beneficial owner or their duly instructed bank, broker or nominee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Vote Required</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">RadNet has implemented
majority voting in uncontested elections of directors. Accordingly, our Bylaws provide that election of a director in an uncontested
election of directors requires the affirmative vote of the holders of a majority of the shares present in person or represented
by proxy on this proposal at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Board of Director Recommendation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">OUR BOARD OF DIRECTORS
UNANIMOUSLY RECOMMENDS A VOTE &ldquo;<B>FOR</B>&rdquo; EACH OF THE NOMINEES ABOVE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROPOSAL NO. 2<BR>
RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Audit Committee
has re-appointed Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December
31, 2020. Ernst &amp; Young LLP has audited our financial statements annually since January 1, 2007. Our Audit Committee reviews
the appointment of our independent accounting firm annually.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At the Annual Meeting,
our stockholders are being asked to ratify the appointment of Ernst &amp; Young LLP as our independent registered public accounting
firm for 2020. If our stockholders vote against the ratification of Ernst &amp; Young LLP, the Audit Committee will consider this
in its selection of auditors for the following year. Even if our stockholders ratify the appointment, the Audit Committee may choose
to appoint a different independent registered public accounting firm at any time during the year if it is determined that such
a change would be in the best interests of RadNet and its stockholders. Representatives of Ernst &amp; Young LLP are expected to
be at the Annual Meeting to answer any questions and make a statement should they choose to do so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Fees Paid to Auditors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
presents fees billed by Ernst &amp; Young LLP for the fiscal years ended December 31, 2018 and 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 72%; text-align: justify"><FONT STYLE="font-size: 10pt">Audit Fees<SUP>(1)</SUP></FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">1,614,836</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">1,850,900</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Audit-Related Fees<SUP>(2)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">150,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">413,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Tax Fees<SUP>(3)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">634,787</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">655,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; text-align: justify"><FONT STYLE="font-size: 10pt">All Other Fees<SUP>(4)</SUP></FONT></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">223,450</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 2.5pt; text-align: justify">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,623,073</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,919,400</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_______________</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: justify"><FONT STYLE="font-size: 10pt"><SUP>(1)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Audit Fees consist of fees billed for professional services rendered in connection with the audit of our annual financial statements and internal control over financial reporting, quarterly review of interim consolidated financial statements and audit services in connection with other statutory and regulatory filings.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: justify"><FONT STYLE="font-size: 10pt"><SUP>(2)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Audit-Related Fees consist of fees billed for assurance and related services that are reasonably related to the performance of the audit or review of our consolidated financial statements.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: justify"><FONT STYLE="font-size: 10pt"><SUP>(3)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Tax fees consist of fees billed for professional services rendered for tax compliance, tax advice and tax planning. These services include assistance regarding federal and state tax compliance, acquisitions and tax planning.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: justify"><FONT STYLE="font-size: 10pt"><SUP>(4)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">All Other Fees consist of fees for products and services other than the services reported above.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Policy on Audit Committee Pre-Approval
of Audit and Permissible Non-Audit Services of the Independent Registered Public Accounting Firm</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a matter of policy,
all audit and non-audit services provided by our independent registered public accounting firm are approved in advance by the Audit
Committee, which considers whether the provision of non-audit services is compatible with maintaining such firm&rsquo;s independence.
All services provided by Ernst &amp; Young LLP during the fiscal year ended December 31, 2019 and the fiscal year ended December
31, 2018 were pre-approved by the Audit Committee. The Audit Committee has considered the role of Ernst &amp; Young LLP in providing
services to us for the fiscal year ended December 31, 2020 and has concluded that such services are compatible with their independence
as our auditors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Vote Required</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ratification of Ernst
&amp; Young LLP as our independent registered public accounting firm requires the affirmative vote of the holders of a majority
of the shares present in person or represented by proxy on this proposal at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Board of Director Recommendation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">OUR BOARD OF DIRECTORS
UNANIMOUSLY RECOMMENDS A VOTE &ldquo;<B>FOR</B>&rdquo; PROPOSAL 2.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROPOSAL NO. 3<BR>
ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with
the requirements of Section 14A of the Exchange Act and the related rules of the SEC, our stockholders have the opportunity to
cast an annual advisory vote to approve the compensation of our Named Executive Officers as disclosed pursuant to the SEC&rsquo;s
executive compensation disclosure rules and set forth in this Proxy Statement including the Compensation Discussion and Analysis,
the summary compensation and other related tables and narratives accompanying those tables (a &ldquo;say-on-pay&rdquo; vote).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We compensate our executive
officers through a mix of base salary, bonus and equity compensation. We intend that our compensation decisions will attract and
retain our Named Executive Officers and reward them for achieving RadNet&rsquo;s strategic initiatives and objective measures of
success. Our Compensation and Management Development Committee and Board of Directors believe that our executive compensation program
is effective in implementing our principles and is strongly aligned with the long-term interests of our stockholders and that our
stockholders should approve our compensation program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We encourage our stockholders
to read the &ldquo;Compensation Discussion and Analysis&rdquo; section above, which describes the details of our executive compensation
program and the decisions made by the Compensation and Management Development Committee in 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The vote on this resolution
is not intended to address any specific element of compensation; rather, the vote relates to the overall compensation of our Named
Executive Officers as described in this Proxy Statement in accordance with the compensation disclosure rules of the SEC. The vote
is advisory and its outcome will not be binding on our Board of Directors nor require our Board of Directors or Compensation and
Management Development Committee to take any action. However, our Board of Directors and Compensation and Management Development
Committee values the opinion expressed by our stockholders in their vote on this proposal and expect to take into account the outcome
of this vote when evaluating future executive compensation arrangements for our Named Executive Officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Accordingly, our stockholders
are being asked to vote on the following resolution at the Annual Meeting:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify">&ldquo;RESOLVED, that the compensation
paid to RadNet&rsquo;s Named Executive Officers, as disclosed in this Proxy Statement pursuant to the SEC&rsquo;s executive compensation
disclosure rules, including Compensation Discussion and Analysis, compensation tables and narrative discussion, is hereby APPROVED.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Vote Required</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Approval of the compensation
of our Named Executive Officers for the stockholder advisory vote requires the affirmative vote of the holders of a majority of
the shares present in person or represented by proxy on this proposal at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Board of Director Recommendation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">OUR BOARD OF DIRECTORS
UNANIMOUSLY RECOMMENDS A VOTE &ldquo;<B>FOR</B>&rdquo; PROPOSAL 3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a45"></A>OTHER MATTERS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We know of no other
matters to be submitted at the Annual Meeting. If any other matters are properly brought before the Annual Meeting, it is the intention
of the persons named in the Proxy Card for the Annual Meeting to exercise their discretionary authority to vote the shares that
they represent in accordance with their judgment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a46"></A>ADDITIONAL INFORMATION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For further information
about RadNet, please refer to the 2019 Annual Report. The 2019 Annual Report is publicly available on the SEC&rsquo;s website at
<I>www.sec.gov</I> and on our website at <I>www.radnet.com</I>. You may also obtain a copy by sending a written request to Investor
Relations, RadNet, Inc., 1510 Cotner Ave., Los Angeles, CA 90025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Some banks, brokers and other nominee record holders
may be participating in the practice of &ldquo;householding&rdquo; proxy statements and annual reports. This means that only one
Notice of Availability or, if you have requested paper copies, only one set of proxy materials is delivered to multiple stockholders
sharing an address. If you are a stockholder sharing an address, you can request a separate Notice of Availability or copy of
the proxy materials by contacting the Broadridge Householding Department by phone at 1-866-540-7095 or by mail to Broadridge Householding
Department, 51 Mercedes Way, Edgewood, NY 11717. A separate copy will be promptly provided following receipt of your request,
and you will receive separate materials in the future. If you currently share an address with another stockholder but are nonetheless
receiving separate copies of the materials, you may request delivery of a single copy in the future by contacting the Broadridge
Householding Department at the number or address shown above.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 50%; text-align: justify"><FONT STYLE="font-size: 10pt">By Order of the Board of Directors,</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><IMG SRC="image_004.jpg" ALT="">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: Red">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">John V. Crues, III, M.D.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>Corporate Secretary</I></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 53 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>VOTE
                           BY INTERNET - www.proxyvote.com</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Use
the Internet to transmit your voting instructions and for electronic delivery of information. Vote by 11:59 P.M. ET on May 29,
2020. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create
an electronic voting instruction form.</FONT></P>



</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><I>RADNET,
        INC.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><I>1510
COTNER AVENUE</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><I>LOS
ANGELES, CA 90025</I></FONT></P>



</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>ELECTRONIC
        DELIVERY OF FUTURE PROXY MATERIALS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">If
you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future
proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery,
please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access
proxy materials electronically in future years.</FONT></P>



</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>VOTE
        BY PHONE - 1-800-690-6903</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Use
any touch-tone telephone to transmit your voting instructions. Vote by 11:59 P.M. ET on May 29, 2020. Have your proxy card in
hand when you call and then follow the instructions.</FONT></P>



</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>VOTE
        BY MAIL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Mark,
sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o
Broadridge, 51 Mercedes Way, Edgewood, NY 11717.</FONT></P>



</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 8pt Arial, Helvetica, Sans-Serif"><IMG SRC="pxycardimage1.jpg" ALT="">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font: 8pt Arial, Helvetica, Sans-Serif"></FONT></P>

<!-- Field: Page; Sequence: 54 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font: 8pt Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"><FONT STYLE="font: 9pt Arial, Helvetica, Sans-Serif"><B>Important Notice
Regarding the Availability of Proxy Materials for the Annual Meeting: </B>The Form 10-K and Notice &amp; Proxy Statement are available at <FONT STYLE="color: blue">www.proxyvote.com</FONT></FONT></P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="border-top: Black 1pt dashed; font-size: 1pt; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<DIV STYLE="border: Black 1pt solid; margin: 0.1in; padding: 0.1in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>RADNET,
                                         INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Annual
Meeting of Stockholders<BR>
June 1, 2020 10:00 AM (Pacific Time)<BR>
This proxy is solicited on behalf of the Board of Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 36.35pt 0pt 36.5pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The
undersigned stockholder(s) of RADNET, INC., a Delaware corporation, hereby appoint(s) Deborah Saly and Mark Stolper, or either
of them, as proxies for the undersigned each with full power of substitution, and hereby authorizes them to represent and to vote,
as designated on the reverse side of this ballot, all of the shares of Common Stock of RADNET, INC. that the undersigned stockholder(s)
is/are entitled to vote at the Annual Meeting of Stockholders to be held at 10:00 AM, PDT on June 1, 2020, at 1510 Cotner Avenue,
Los Angeles, CA 90025 or by means of remote communication, and any adjournment or postponement thereof. The undersigned hereby
acknowledges receipt of the Notice of Annual Meeting of Stockholders and the accompanying Proxy Statement and revokes any proxy
heretofore given with respect to such meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 36.35pt 0pt 36.5pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 36.35pt 0pt 36.5pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>This
proxy, when properly executed, will be voted in the manner directed herein by the undersigned stockholder. If no direction is
given, this proxy will be voted &quot;FOR&quot; each of the nominees for director and &quot;FOR&quot; proposals no. 2 and 3 as
described in the Proxy Statement.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 36.35pt 0pt 36.5pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.55pt 0pt 36.5pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>If
any other business is presented at the Annual Meeting, this proxy will be voted in accordance with the best judgment of the named
attorneys-in-fact.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.55pt 0pt 36.5pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.55pt 0pt 36.5pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Address change/comments:</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border: Black 1pt solid; width: 100%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt; text-align: center"></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 5.4pt; text-align: center; margin-bottom: 5.4pt">&nbsp;&nbsp;<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">_________________________________________________________________________________&nbsp;&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 5.4pt; text-align: center; margin-bottom: 5.4pt">&nbsp;&nbsp;<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">_________________________________________________________________________________&nbsp;&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 5.4pt; text-align: center; margin-bottom: 5.4pt">&nbsp;&nbsp;<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">_________________________________________________________________________________&nbsp;&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

</TD></TR>
</TABLE>

<P STYLE="margin: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 4.2pt 6.5pt 0; text-align: center"><FONT STYLE="font: 8pt Arial, Helvetica, Sans-Serif">(If
you noted any Address Changes and/or Comments above, please mark corresponding box on the reverse side.)</FONT></P>



<P STYLE="margin: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt; text-align: left"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Continued
                                         and to be signed on reverse side</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>&nbsp;</B></FONT></P>

</DIV>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" "@ 74# 2(  A$! Q$!_\0
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M3^1K0\,_L+_"[0KG[5<^$],UZ^)R;C68EOFSZA) 8U/?Y5&*]>* ]J1QM'%
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M9_#I?#.WQE;ZK-?OJM@UTRFV:S$>S#J!D3OG.<\=,5^?O_$31^TYC_6?#O\
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M/_8UT_QUXT_LS^WKG5]1L7-A;FW@\N"Y:./"[FYV@9.>32\POK8^G**^4?\
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M\:CBK"TJ,:5:DDG?I]YU^#>=8S&UL9@,9-U*=D_>=[7;36M]&NFVGF?T'?\
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MX]^*=/\ '7[1GCC7=(O(=0TC7?$M_J=A=1-NCN;:>Y>:*13Z,CJ1]17Z$?\
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M6]I4I86.KO?[]$B_!3 RPF#QF<8E<M.RLWU4;N37X+U3/Z!O^#7SP1_PCO\
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MV2])/[ 7Q@?X WRK#\.O$US=ZM\);W>3':Q?-<7OAM\_=DM<O/;98F6U:10
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M. 37W)_P6Q^+A\&?LN:?X7MY%6\\<:M';N"<%;2W!GF?TQO6!"#VE/I7'_\
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6FB\UW"':HKW:(;3C_)H DHHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  : &\# 2(  A$! Q$!_\0
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(0 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>pxycardimage1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 pxycardimage1.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" )! T\# 2(  A$! Q$!_\0
M'  !  ,! 0$! 0            0%!@<# @$(_\0 6!   0,# P(!!0L(!P4%
M!P,% 0(#!  %$082(1,Q(@<4%4%1%C(U4E9A<Y&QT=0C-E5Q@I.BLC-"5X&5
MIM(D-W6ALQ=B<I*U"!@E4Y3!TR9CM#1#17;P_\0 %P$! 0$!
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M;!QMQW.<\8JO<O=_EWJ3]Q;OPM!JJ556^US(MJDQ'[[<IDAW=LFOMQP\SE(
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M1M.3R%''B-(JHO>4>]_Q)Z;U]J_O2WUHO7RM571B#$MQ:>CL*5=PMSF"^%%
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M/17>EKC^BG/K/W4]+7']%.?6?NJC:U]U$H(M,CP=0R-R]A:"%H22 H G/4!
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M!)(R 1P<=ZGTH*N5IVR3$!$NSVU] <0Z$NQ4*&] "4JY'<   ]P !5H0",$
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M*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!7
M/_;6_P!UEJ_XTU_T'Z[_ %P#_P!M;_=9:O\ C37_ $'Z#JODG_W6:-_X+"_Z
M"*U597R3_P"ZS1O_  6%_P!!%:J@K-2_ DG]G^85(L_P5$^B3]E1]2_ DG]G
M^85(L_P5$^B3]E!+I2E!12_SNA?0G[%U>U12_P [H7T)^Q=7M KR7)81*;C+
M?:3)<2I:&BL!:DIP%$#N0-PR?5D>VO6L7+LG3\K=LO#,>2OJVR4R^^2M3:,+
M8V(^*G.%G QGD\XJQ%S7[])E8AM*\9DJ/!B/2IK[4>,R@K=>=6$(0D<DJ4>
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M6F*H/EU/"VP$C<$X2HN X(R0,5N-(V:TP8D>79)0E1EL;$/-K;4VXDK*RH;
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MR9CB_P#:4M/LO*87YPX]RC:0,+4H84",) (.#6SM6G85L3;1&+H$%IUIL':
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M?;Q<1VWFUOEY\O)6YN;!0$]-. -O'?D$Y/M^:J^59?.-2PKQZ1FMF*PXP(J
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MH"2T RM3R7MZ3LR2%H21O*N..1Q4@Z-BJ6RMRXW-PC;YP5NI/G>UTNI#AVY
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MP;3RM0&3_P!Y7]]9NV:#GLZ-L,1%S3$O<1IPR9+C/G"7%O@]?(W)Y).0K/!
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MOS27O^6Z72N>7?4C\2Y7P.7M;#T9+P;MR(K:RAM+25)>R<$<D^)2MA[8R,U
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MG\F<$E.4\>'VYK"7?6EP:O5T8;OGFT9#FU2EA@JBA,QEHG9M)2-BU<N%6??
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M*4()V;>5Y/'%2(N(GFM:]'7J5R:SZFOEWE"*+C)BJ=DMH>4&XRE15%3FYI(
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MMQW[-36=(USO$R!>RVZP@QD6U^6 A[.];9;R""C(]]@$*]9R.V*-[7=Q;BR
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M6XRAU A*,H*76R 0A.0<\^RMC2@H=)V!RR(N#TV;Y]<;A(\YE/I:Z2%+"$H
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MU>M;V*SW!R#+>F.RFP"XW#M\B7T\C("RTVH))'.#@XK2UC= _G!KGV^F1_\
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MP5$^B3]E!+I2E!12_P [H7T)^Q=7M44O\[H7T)^Q=7M I2E I2E I2E I2E
MI2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E
MI2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E
MI2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E
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M]O$$J""\9*-B5D ["K. KGMFG07%*KS>[4)SD(W.")C:2M;!D(ZB4@9)*<Y
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ML75[0*^%LM+=;=6VA3K>=BRD$ISWP?5FONE I2E I2E I2E I2E I2E I2E
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MJ)! ()R@#ZZQUVTOIST7JB/:+G;1)D-+9E=:2TV(*7'"5K4I"=^0K)'4)Y2
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M^"2E4N"Y'"P%("5-'IHV#C;D@;L\YSS3C-;SG?F997O*-^75.GSK"W,FRV[
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M$K2EA#A;'K*"%!(2?U?/7M.AZ=D:?;>:U(F)#2^^4W!B6SC+Y45M[E HP=_
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MXXXU)<0[M4ZII,?H-'#1/@ZFXDC;XLDU8VB!-N%XA(==O[5G1YVMGJ2)#*R
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MI(6M<"1%;W M%O<$I*%1FVE9RTL<;#P ,@^^35V-,/"UZCBK\U?7<L!M3A6
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M!E?=1=_D)J3]_;OQ51+MKB;:+5-N5PT3J1F%#97(?<ZL!6QM"2I1P)1)P >
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M^YR+D9[?UO746S1X_N@TFJ1IYQ/1F2RW)8LLA#6Q0.QPA25= %9)VJ4 /?#
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M250I"4@E1;4 !Z^*F*:B9:B+FG+F]&^4MU&YKROI6D^M.FXI'\U?7N)\I_\
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M0)"=I%7ODX+ATC%2LE32'7VXY/K82\L-?W; FD1E9.4TQ_N)\I_]KG^6HO\
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MXMRKW$^4_P#M<_RU%_U5%NWDY\HMWM4VVW#RL=:%,97'?;]SD9.]M:2E0R%
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$*#__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
